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Abstract.We provide a rationale for and describe examples of synthetic modeling and simulation (M&S)
of biological systems. We explain how synthetic methods are distinct from familiar inductive methods.
Synthetic M&S is a means to better understand the mechanisms that generate normal and disease-related
phenomena observed in research, and how compounds of interest interact with them to alter phenomena.
An objective is to build better, working hypotheses of plausible mechanisms. A synthetic model is an
extant hypothesis: execution produces an observable mechanism and phenomena. Mobile objects
representing compounds carry information enabling components to distinguish between them and react
accordingly when different compounds are studied simultaneously. We argue that the familiar inductive
approaches contribute to the general inefﬁciencies being experienced by pharmaceutical R&D, and that
use of synthetic approaches accelerates and improves R&D decision-making and thus the drug
development process. A reason is that synthetic models encourage and facilitate abductive scientiﬁc
reasoning, a primary means of knowledge creation and creative cognition. When synthetic models are
executed, we observe different aspects of knowledge in action from different perspectives. These models
can be tuned to reﬂect differences in experimental conditions and individuals, making translational
research more concrete while moving us closer to personalized medicine.
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INTRODUCTION
The declining pace of new drug approvals, general
inefﬁciencies, and signiﬁcant rates of failures late in develop-
ment are among the factors contributing to calls for reexami-
nation of the methodological robustness of pharmaceutical
and biotechnology research and development (R&D) (1–4).
Among the inefﬁciencies is the fact that scientists and
decision-makers translate results and conclusions from wet-
lab experiments to patients using conceptual mappings where
some assumptions about the wet-lab-to-patient mappings are
intuitive and unknown, and thus unchallengeable. Those
conceptual models exist in and rely on the minds of a
changing cadre of domain experts. It has been argued that
mathematical, systems biology models will help to address
this issue, but we argue that primary reliance on the familiar
inductive and deductive computational modeling methods
will be inadequate: success requires that they be augmented
with new classes of models and methods. Within the past
decade, an expanding number of groups, working within
different domains, have contributed to the development of a
class of computational models that we argue can dramatically
increase the efﬁciency, efﬁcacy, reliability, and variety of
plausible translational mappings, and thus facilitate and
accelerate better decision-making.
To distinguish this class of models and its methods from the
more familiar inductive mathematical modeling methods, we
identify it as the synthetic (combining elements to form a whole)
method of modeling and simulation (M&S). Our objective is to
draw on recent examples to help make a case for the use of
syntheticM&Swithin the critical decision-making stages of drug
discovery and development. We explain 1) how synthetic M&S
is made scientiﬁc 2) how synthetic M&S can augment mental
models and system thinking with concrete virtual tissues, organs,
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and ultimately virtual patients; and 3) that synthetic M&S
enables explorable, in silico wet-lab-to-referent mappings that
are accessible to all members of an R&D organization as
operating models of current knowledge and beliefs. More
important is that synthetic M&S encourages and facilitates
abductive reasoning (see Appendix for explanation): the
primary means of knowledge creation and the primary source
of creative leaps. The more mature descendants of these
models may even begin capturing the gestalt of successful
pharmaceutical R&D.
While it is true that no computational model can fully
represent the complexity of biological systems, new model
types are essential to achieving deeper insight into the causal,
mechanistic networks responsible for disease and desired
pharmacological phenotypes. We show how synthetic M&S
can be used to discover, clarify, and challenge plausible
linkages between biological mechanisms and phenotypes.
Skeptics may also declare that models cannot mimic the
complexity inherent within biology and thus cannot be
correct. However, the advance of science depends on discov-
ering and using better models. It will become clear how
validation-supported synthetic models (deﬁned in the Glos-
sary) can expedite and improve R&D decision-making.
The text that follows is divided into ﬁve sections. In
“Rationale for New Model Classes,” we provide our rationale:
we make the case for needing new classes of models and discuss
how they are created. We follow that in “Analogues: From In
Vitro Tissues to Interacting Organs” with descriptions of four
examples of system-oriented, synthetic, biomimetic models that
have provided new mechanistic insight into phenomena
observed in vitro and in vivo. Those motivating examples
provide context for “Reasoning Types and Their Different
Roles in M&S,” which discusses how the three types of
reasoning—induction, deduction, and abduction (in Glossary)
—are used in science andM&S.We describe how the two classes
of models, inductive and synthetic, draw differently on induc-
tive, deductive, and abductive reasoning to achieve their differ-
ent objectives. Coupling the capabilities of well-established
mathematical modeling methods with those of synthetic M&S
will, for the ﬁrst time, make the full power of the scientiﬁc
method available to the M&S component of R&D. That
discussion leads directly to “M&S and the Scientiﬁc Method,”
in which we develop the idea of scientiﬁc M&S (in Glossary). In
the penultimate section, “Impact of M&S on Scientiﬁc Theory,”
we explain what it can accomplish. We argue that in order to
achieve the above vision, we must expand computational M&S
into scientiﬁc M&S. We provide a list of eight capabilities that
synthetic models will need in order to achieve our vision. We
then summarize in the Conclusions. A glossary of less familiar
terms is included in the Appendix along with essential support-
ing information, including brief descriptions of inductive,
deductive, and abductive reasoning. For convenience, selected
key points made in “Rationale for New Model Classes,”
“Reasoning Types and Their Different Roles in M&S,” “M&S
and the Scientiﬁc Method,” and “Impact of M&S on Scientiﬁc
Theory” are provided as bulleted statements at the start of each
subsection. A relatively comprehensive bibliography of primar-
ily discrete event (in Glossary) biomedical models that combine
synthetic and inductive methods is provided as Supplemental
Material. See (5–11) for reviews of advances in and relevant
biomedical applications of inductive mathematical M&S.
RATIONALE FOR NEW MODEL CLASSES
Envisioned New Model Classes
& Building an experimental apparatus is fundamentally
different from “modeling the data.”
& An objective is to build better working hypotheses
about mechanisms.
What spatiotemporal mechanisms play roles in the
emergence (in Glossary) of a pharmacological response?
During drug discovery and development, current knowledge
is often inadequate to answer that question. A research
objective is to develop better working hypotheses about those
mechanisms. Synthetic models can expedite that process. A
dictum of the physicist Richard Feynman was “what I cannot
create, I do not understand.” It follows that to understand
biological responses and their plausible generative mecha-
nisms when uncertainty is large and data are chronically
limited, we need to build extant (actually existing, observ-
able), working mechanisms that exhibit some of those same
phenomena. Building extant, plausible, analogue mechanisms
is fundamentally different from the traditional approach of
“modeling the data.” In the latter case, the mechanisms are
all conceptual. We cannot yet build hierarchical, modular,
extant mechanisms out of biochemicals. However, as
described below, we can build extant biomimetic mechanisms
using object-oriented software tools.
Consider the following: A software engineer, given com-
plete freedom, creates code that, when executed, produces
mechanisms which give rise to multi-attribute phenomena that
are strikingly similar to speciﬁed pharmacological phenomena.
When the software engineer has limited biological knowledge,
there may be no logical mapping from event execution in the
simulation (in Glossary) to the biology during observation.
However, biologically inspired requirements can be imposed to
shrink and constrain the space of software mechanism and
implementation options that successfully exhibit those same
phenomena. A continuation of that process can lead to extant
software mechanisms (and phenomena) that are increasingly
analogous to their biological counterparts. In so doing, we are
not building amodel based exclusively on known biological facts
and assumptions, because the facts are often insufﬁcient to do
so. Furthermore, keeping track of all the assumptions and
assessing their compatibility can become an unwieldy, time-
intensive task. Rather, we are exploring the space of reasonably
realistic, biomimetic mechanisms that can cause the emergence
of prespeciﬁed pharmacological phenomena. The focus is on
inventing, building, exploring, challenging, and revising plau-
sible biomimetic mechanisms. To distinguish the two modeling
methods and help ensure a disciplined focus on methodology,
we refer to models arrived at through the latter process as
(biomimetic) analogues (in Glossary). To emphasize aspects of
construction and method, speciﬁcally combining often varied
and diverse elements, so as to form a coherent whole, we say
synthetic analogues.
Bridging the Gap Between Wet-Lab and Traditional,
Computational Models
& Gap-bridging computational models will be objects of
experimentation, similar to wet-lab models.
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To achieve our vision, we need in silico models that are
different from the familiar inductive pathway, network, tissue
transport, pharmacokinetic (PK), pharmacodynamic (PD),
physiologically based (PB), and other related models. Synthetic
models will have more in common with the wet-lab systems that
they represent than with the current generation of equation-
based models. Fig. 1 depicts the space of major model classes
used today in pharmaceutical and biotechnology research.
Model types on both sides have different uses. The ultimate
referents for both are speciﬁed subsets of patients. Not
represented are the conceptual mental models on which all
scientists rely and the prosaic models (often supported by
sketches of idealized mechanistic events) that describe these
mental models. Moving to the right in Fig. 1, model aspects (in
Glossary) become more realistic, relative to their referents.
Moving up, similarities between model and referent attributes
increase: the models become more biomimetic. The diagram
excludes patients. Model organisms are in the upper right. In
vitro cell and tissue models are next. Below them are cell-
derived systems. Statistical and correlative models are to the
lower left. Above them are the familiar, induced mathematical
computer models. Included within the latter are network,
pathway, PK, PD, and PB models; they are induced from data.
The space above them includes inductive models based on
discrete event formalisms, such as cellular automata (CA),
cellular Potts models (CPM) (12–14), pi-calculi (15–17), etc.
In order to demonstrate that we understand howmolecular
level details interface with and exert inﬂuence at higher levels
and emerge as features of a favorably altered patient phenotype,
we need models and methods that can bridge the gap. We need
models that are increasingly more like their referents—models
that have extant mechanisms that generate emergent properties
analogous to how phenomena emerge during wet-lab experi-
ments. Those models will be synthetic, as are wet-lab models.
An important use for such models will be testing hypotheses
about mechanisms (rather than about patterns in data).
However, it is important to note that network, PK, PD,
and other mathematical modeling methods do not need
replacing—they do what they are intended to do very well,
even though they will beneﬁt from improvements. Never-
theless, to span the gap, we will need new model classes
having new uses and capabilities (see Text Box below).
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Instantiating a Mechanistic Hypothesis and Achieving
Measurable Phenotype Overlap
& A synthetic analogue is an extant hypothesis: execu-
tion produces an observable mechanism.
& Analogues that are scientiﬁcally useful will have few
1:1 model-to-referent mappings.
When object-oriented, software engineering methods are
used to implement a mechanism on the right side of Fig. 2, the
product of the process is an extant hypothesis: these
components (objects) will produce a mechanism upon execu-
tion. By so doing, we have instantiated (represented with a
concrete instance) a mechanism in silico. A consequence of
mechanism execution will be the emergence of phenomena
that are similar (or not) to prespeciﬁed phenomena, such as a
response following exposure to a xenobiotic. Execution
produces a simulation with features that we can measure;
those measurements enable testing the hypothesis. If phe-
nomena similarities meet some prespeciﬁed criterion, then
the simulation stands as a challengeable yet tested theory
about abstract yet plausible mechanistic events that may have
occurred during the wet-lab experiments.
There is an important lesson in the fact that in vitro
models are useful, yet fundamentally different from their
animal and patient referents, a lesson that can help provide
guidelines for building scientiﬁcally useful synthetic analogues
capable of bridging the gap. To present the lesson, we use a
speciﬁc example, though the ideas are generalizable. The
example wet-lab system is cultured Madin-Darby canine
kidney (MDCK) cells, a well-established in vitro cell line.
Epithelial cell cultures are widely used as model systems to
support research in drug discovery and development. The
Venn diagrams in Fig. 3 illustrate phenotypic relationships.
There is overlap (measurable similarities and identiﬁed
mappings) between phenotypic attributes of MDCK cell
cultures and epithelial cells within a tissue, even though this
phenotypic overlap is limited. By phenotype, we mean the
variety of tissue attributes and cell behaviors associated with
several aspects of each system, observed from particular,
Fig. 1. Illustrated is the gap that exists between inductive, mathe-
matical models and the wet-lab models used in biomedical research.
For illustration purposes, model types, and the analytic and explan-
atory methods that use them, are arranged according to abstraction
level versus biological character; in reality they are not independent.
The arrangement of model types is discussed in the text. More
abstract indicates a greater capability for simple and focused
representation. More realistic indicates a greater capability for
aggregating collections of facts. The biological axis (biomimetic)
indicates the degree to which a model resembles and behaves, at
some level of detail, like its wet-lab referent. An inductively deﬁned,
equation-based model, for example, can mimic time-course measures
of an aspect of a biological system very well (high, aspect-speciﬁc
biomimesis), but, as a complex algorithm implemented atop a
numerical integrator, it is not at all realistic (yet the conceptual
model to which it is tied may include some realistic features). An
unvalidated agent-based model can implement detailed representa-
tions of almost any physiological process and yet be incapable of
behaving like the referent in any particular context; hence, it exhibits
high realism but little biomimicry. Models that can bridge the gap will
be biomimetic analogues of their wet-lab counterparts; they can be
used for evaluating explicit mechanistic hypotheses in the context of
many aspects of the referent.
Fig. 2. Model-referent relationships (adapted from Fig. 1 in (65)).
Shown are relationships between wet-lab, perfused liver experiments
(center), traditional PK models (left), and In Silico Liver (ISL)
analogues, which have begun bridging the gap in Fig. 1. Center: Rat
livers in an experimental context (as in (89)) are the referent systems.
During experiments, hepatic components interact with transiting drug
molecules to cause changes in a drug’s concentration-time proﬁle.
The system’s behaviors during the experiment are reﬂected in the
collected data. Left: The researcher identiﬁes patterns in the data:
drug (and possibly metabolites) levels in the hepatic out-ﬂow proﬁle.
From those data and prior knowledge, an abstract, mechanistic
description of what is thought to have occurred is offered, thus
establishing abstract, conceptual mappings from that description to
hepatic mechanisms. One or more equation-based PK models are
selected, they are believed to be capable of describing the time course
patterns identiﬁed in the data. The equations are known to be
consistent with an idealized version of the mechanistic description.
There is a conceptual mapping from that description to the equations.
Software is executed to simulate parameterized equation output,
enabling a quantitative mapping from simulated output to PK data.
Metrics specify the goodness of ﬁt. Right: A plausible, abstract
mechanistic description is hypothesized and speciﬁed; it is similar but
not identical to the one on the left side. Software components are
designed, coded, veriﬁed, and assembled, and connected guided by
the mechanistic speciﬁcations. The product of the process is a
collection of micro-mechanisms rendered in software. A clear,
concretizable mapping—C—exists between in silico components and
how they plug together, and 1) hepatic physiological and micro-
anatomical details, and 2) drug interactions with those components.
Execution gives rise to a working analogue. Its dynamics are
observable and intended to represent (mapping B) corresponding
dynamics (believed to occur) within the liver during an experiment.
Mapping B is also concretizable. Simulation measures provide time
series data that are intended to mimic corresponding liver perfusion
measurements. Quantitative measures establish the similarity
between the two outﬂow proﬁles (mapping A).
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comparable perspectives. Although phenotypic overlap is
limited, in vitro models are extremely useful systems for
understanding in vivo biology. Similarities do exist, and
conceptual models that are broadly accepted provide descrip-
tions of plausible relationships. Experimenting on MDCK
cultures improves the researcher’s insight into epithelial tissues.
They have also proven useful because MDCK cultures are
simpler (more abstract) and more easily controlled than in vivo
systems, and thus more easily studied and understood.
Although there are many similarities in measurable
phenomena between systems, there are few precise, one-to-
one behavioral mappings between structures in MDCK
cultures and epithelial cell structures within mammalian
tissues. True, there is a 1:1 correspondence between cells.
However, because cell environments and genetics are differ-
ent (cannot be precisely duplicated), mappings between in
vitro and in vivo, which can be aspect- and perspective-
dependent, may be nonlinear and in some cases complex (in
Glossary). That observation is instructive. It suggests that an
in silico analogue can become a scientiﬁcally useful repre-
sentation of MDCK cultures (and eventually epithelial cells in
tissues) without enforcing 1:1 mappings between its attributes
and mechanisms and measures of cultured MDCK.
We can characterize wet-lab models that have extended
lifetimes and are used in different experimental contexts with a
variety of designs as being robust to context, even though its
referent is speciﬁc. We need synthetic analogues that can be
characterized similarly. The mappings from wet-lab model to
referent are often somewhat different for each context because
the aspect of interest will have changed. We can surmise that
an analogue built initially to have many 1:1 model-to-referent
mappings may be solidly anchored to one referent aspect and
attribute, and thus may have limited additional uses (without
undergoing considerable reengineering).
Absent precise 1:1 mappings, scaling methods will be
needed; their development can be separated from that of the
analogue. The mechanisms responsible for generation of an
MDCK culture phenomenon (e.g., stable cyst formation) are
not grounded to any external measurement methods. Nor are
they grounded directly to a tissue referent. The units, dimen-
sions, and/or objects to which a variable or model constituent
refers establish groundings (in Glossary and discussed further in
“How aModel is Grounded Impacts How It Can and Should Be
Used”). The components of parameterized PK models are
typically grounded to metric space. The components of MDCK
mechanisms are grounded to each other. The grounding of cells
to each other and their environment is independent of any
measures. From that fact, we can infer that analogues that
bridge the gap will exhibit similar grounding. We measure wet-
lab phenomena using metric devices. We cannot use those same
devices to measure events during simulations.
Analogues That Bridge the Gap Will Be Executable
Knowledge Embodiments Suitable for Experimentation
& Synthetic models present different aspects of knowl-
edge in action, and do so from different perspectives.
& Separate, tuned copies of successful analogues can
reﬂect differences in individual-speciﬁc attributes.
Fig. 3. Shown are examples of phenotype overlap. The shaded areas illustrate sets of
phenotypic attributes. There is overlap (clear, direct similarities) of some systemic
attributes of MDCK cultures and corresponding epithelial cell attributes in mammalian
tissues. In the non-overlapping regions, the mapping between related attributes (and their
generative mechanisms) is not straightforward. It is complex. An in silico, synthetic
analogue of the class described on the right side in Fig. 2 can have a similar relationship to
MDCK cultures. Grant et al. provide an example (86) in which cell components are quasi-
autonomous. There is a set of operating principles along with component logic governing
component interactions. Phenotypic attributes observed during execution are unique.
Overlap (similarities) in phenotype between the analogue and MDCK cultures are
intended to reﬂect similarities (but not precise matches) in components, mechanisms, and
operating principles. A As in (86), the ﬁrst analogue is simple and abstract. It validates
when a set of its attributes are acceptably similar to a targeted set of MDCK culture
attributes (area of overlap). As is the case with MDCK cultures relative to epithelial cells
in mammalian tissues, the analogue will have attributes that have no MDCK counterparts
(non-overlapping area). B Sequential, iterative reﬁnement (see Fig. 12) of the ﬁrst
analogue leads to an improved analogue. Kim et al. provide an example (81). Its validation
is achieved when an expanded set of its attributes are judged similar to an expanded target
set of MDCK attributes.
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In synthetic analogues such as the In Silico Livers (ISLs)
discussed below, components and their interactions represent
micro-mechanistic features, including anatomical, physiolog-
ical, and molecular details at different levels during execution.
Because of such multi-level similarities, following several
rounds of improvement, testing, and validation, descendant
analogues of this class have the potential to evolve into
executable representations of what we know (or think we
know) about biological systems: executable biological knowl-
edge embodiments. We expand on that idea below; see (18)
for further discussion. Such embodiments are needed but are
beyond the scope of current PK, PD, and related modeling
methods. Knowledge embodiment is made feasible because
synthetic analogues provide concrete instances of that knowl-
edge rather than computational descriptions of conceptual
representations. When an analogue is executed, it demon-
strates when, how, and where our knowledge matches or fails
to match details of the referent system. For that reason,
Fisher and Henzinger (19) suggested referring to such
simulation models as executable biology.
The envisioned synthetic analogues can facilitate the
merger of knowledge and expertise contributed across organiza-
tional domains into executable and, therefore, observable and
falsiﬁable systems of plausible mechanisms and hypotheses (20).
Together, they will represent the current best theory for aspects
of system function. It will be possible to observe different aspects
of knowledge in action and do so from different perspectives, as
we do with wet-lab systems. Adjusting (tuning) an ISL to
represent (for example) a normal rat liver in one in silico
experiment, a diseased rat liver in another (as in (21); see “In
Silico Livers”), and a mouse or human liver in another will be
relatively straightforward because uncertainty can be preserved
and cross-validation of component functions can specify which
features to tune and by how much. It will be feasible to take
copies of the same analogue and tune each separately to reﬂect
differences in measured, patient-speciﬁc attributes. The collec-
tive knowledge coupled with collective uncertainty can be made
speciﬁc for groups of patients and even for individual patients.
Achieving the Vision Motivating Physiologically Based
Pharmacokinetic (PBPK) Modeling and Simulation
& To discover and test plausible mechanistic details, we
must experiment on (different) synthetic analogues.
A vision motivating research on synthetic analogues is
identical to one that has motivated development of traditional
PBPK models: by “accounting for the causal basis of the
observed data, ... the possibility exists for efﬁcient use of limited
drug-speciﬁc data in order to make reasonably accurate
predictions as to the pharmacokinetics of speciﬁc compounds,
both within and between species, as well as under a variety of
conditions” (22). However, PBPKmodel parameters necessarily
conﬂate features and properties of the biology (aspects of
histology, etc.) with drug physicochemical properties (PCPs)
(23). In doing so, “the causal basis” becomes obscured due to
the conﬂated biological features that were especially inﬂuential
in causing some pattern in the data.
A purpose of conducting PK and other experiments that
provide time course data is often to shed light on prevailing
mechanistic hypotheses about drug dynamics, speciﬁcally to
gain new knowledge regarding mechanistic details of dispo-
sition and metabolism. Most often, hypotheses about those
details are induced from the data. Fitting inductive mathemat-
ical models to data is often used as evidence in support of
particular hypotheses. To date, designing and conducting new
wet-lab experiments has been the only practicable means to
experimentally falsify those hypothesized, conceptual mecha-
nisms. Experimenting on synthetic analogues provides a
powerful new means of discovering and testing the plausibility
of mechanistic details. A traditional, inductive, PK model
hypothesizes an explanation of patterns in PK data (24). The
mathematics of PBPKmodels describe data features predicted
to arise from conceptualized mechanisms, which are typically
described in sketches and prose. As illustrated on the left side
of Fig. 2, there are unveriﬁable, conceptual mappings between
equations and envisioned mechanisms. The methods used by
synthetic analogues, as exempliﬁed by the four cases described
in “Analogues: From In Vitro Tissues to Interacting Organs,”
are different. They provide an independent, scientiﬁc means to
challenge, explore, better understand, and improve any
inductive mechanism and, importantly, the assumptions on
which it rests.
Creating Synthetic Analogues and Defining Their Use
& Models that begin spanning the gap in Fig. 1 are
generalized object- and agent-oriented constructions.
& Biomimetic agent-based analogues facilitate discov-
ery and understanding of phenomena produced by
systems of interacting components.
& Important use: better understand disease mechanisms
and their interactions with interventions.
& By nesting agents and objects hierarchically, one can
discover plausible upward and downward mechanistic
linkages.
The biological mechanisms that generate system level
phenomena are consequences of components at multiple levels
interacting in parallel, primarily discretely, with other compo-
nents in their local environment. Simulation of such behavior
can and has been achieved by adopting discrete event M&S
methods. Any interaction can be stochastic. So doing simulates
uncertainties and is a means to preserve ignorance. See (25,26)
for a generalized discussion of the advantages of using discrete
event methods to model and simulate complex adaptive
systems. Fisher and Henzinger (19) discuss how several formal,
discrete event methods (Boolean networks, Petri nets (27), pi-
calculi, interacting state machines, etc.) have been leveraged to
gain mechanistic insight into biological phenomena. Advances
in simulating complex biological phenomena have been
accomplished using formal cellular automata (28–42) and
cellular Potts models (13,43–52).
Most biological components are spatially organized,
semi-modular, and quasi-autonomous: they include organs,
tissue functional units, cells, subcellular systems, and macro-
molecular complexes. Synthetic analogues must be capable of
exhibiting those same attributes. Greater component
autonomy coupled with realistic yet abstract, spatially organ-
ized, biomimetic mechanisms have been achieved using
agent-based and agent-oriented methods (53–55). Because
all of the preceding methods are based ultimately on object-
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oriented programming (in Glossary) methods, we suggest that
analogues that begin spanning the gap in Fig. 1 will be
considered generalized constructions in the object-oriented
domain that uses agents (in Glossary). Consequently, we
focus the following discussion on those methods. The four
examples described in the sections that follow all use agents.
In agent-based (in Glossary) modeling, quasi-autonomous,
decision-making entities called agents are key components;
see Appendix for available multi-agent M&S platforms.
Other components, such as those representing speciﬁc com-
pounds (biochemicals or xenobiotics), can be simple, reactive
objects or properties of spaces. Reactive objects and agents
follow sets of rules that govern their actions and interactions
with other system components. In this context, an agent is a
biomimetic object that can be quasi-autonomous; it has its
own agenda and can schedule its own actions, much like we
envision a cell or mitochondrion doing. When needed, an
agent can change its operating logic. Agent-based modeling
facilitates the production of systemic behaviors and attributes
that arise from the purposeful interactions of changeable
components. The resulting biomimetic analogues have advan-
tages when attempting to understand and simulate phenom-
ena produced by systems of interacting components, and that
makes them prime candidates for bridging the gap in Fig. 1.
If we had analogues of the type just described, how would
we use them in the context of drug discovery and development
research? An important use would be to understand the
mechanisms that generate disease-related phenomena and
how compounds or formulations that interact with the
mechanisms can alter those phenomena. Improved mechanis-
tic knowledge will enable improved predictions, while helping
to reduce requirements for new wet-lab experiments.
A feature of object-oriented analogues is that objects
and agents can be either atomic or composite. Atomic
components deﬁne the system’s level of resolution—its
granularity (in Glossary). Granularity is the extent to which
a system is subdivided, with the smallest components being
atomic. An atomic object has no internal structure and so
cannot be subdivided—it simply uses its assigned logic.
Granularity is also the level of speciﬁcity or detail with which
system content is described: the more ﬁne-grained, the more
speciﬁc. Objects, both atomic and complex, are pluggable and
can be replaced (as distinct from being subdivided) with more
ﬁne-grained, composite components that exhibit the same
behaviors within the analogue under the same conditions.
That replacement can even take place during a simulation.
These components can exhibit hierarchical nesting, which
makes it feasible to use analogues of this class to begin
discovering plausible upward and downward linkages that are
needed to enable instantiating (in Glossary) details of
genotype-phenotype linkage. When the nested components
are relationally grounded, one can avoid many of the multi-
scale problems that plague metrically grounded, equation-
based, inductive models. The phenomena emerging from
mechanisms at one level can be used as input at another level.
Greater nesting means more components, and that means
more interactions and more simulation time to process,
document, and record those interactions. In order to maintain
parsimony, analogues should be designed with components
that are just ﬁne-grained enough to produce targeted
phenomena and achieve the analogue’s speciﬁed uses.
Representing Chemical Entity Attributes and Dynamics
Within Biomimetic Analogues
& Components base their actions on information pre-
sented by the mobile objects (compounds) they
encounter.
& Each type of component–compound interaction is a
simple micro-mechanism.
& Components use simple logic to tailor their micro-
mechanism to a subset of a compound’s properties.
Recent reviews of in silico prediction of absorption,
distribution, metabolism, excretion, and toxicity (ADMET)
properties and of quantitative structure-activity relationship
(QSAR) methods chronicle advances in technical sophistica-
tion, plus increased use of consensus modeling. They also
point out pitfalls of complicated correlation methods. Sat-
isfaction with the quality of PCP predictions is counter-
balanced by disappointment in predictions of organism-based
properties for new compounds (56–62). Johnson reminds us
(61) that many, nearly equivalent, correlational models are
possible, making it easy to choose a wrong model for the
next new compound. Furthermore, many of the models have
no grounding in biological reality. A take-home message is
that useful, reliable ADMET predictions of organism-based
attributes of future compounds will need to be based on
mechanistic insight. The representations of compounds
within synthetic analogues, along with their interactions
with system components, provide a new, potentially power-
ful approach to thinking about organism-based, structure-
activity relationships.
Precise knowledge of the stoichiometry of biological
component–compound interactions is rarely if ever available.
Uncertainties at all levels are common. An advantage of
discrete event methods is that both knowledge and ignorance
(uncertainties) can be represented concurrently. Precise yet
poorly informed assumptions can be avoided. The effective
stoichiometry of inﬂuential, low level (ﬁne-grained) interac-
tions involving compounds can be represented at almost any
convenient granularity level below that of the targeted
phenomena, but the mappings from objects representing
compounds to their referent molecules are not 1:1. Early in
the analogue development process a scientiﬁcally justiﬁed
level (moving down from targeted phenotypic attributes) at
which to initially represent compounds is the ﬁrst at which
biological functional units are encountered, and that is
typically a coarse-grained representation.
The presence of a compound can be represented as a
property of a space or as mobile objects. We focus on the
latter. Mobile objects representing chemical entities can map
to an arbitrary number of molecules (see Appendix, Repre-
senting Compounds). During simulations such objects are
typically passive. The agency (interaction-speciﬁc program-
ming logic) to determine the outcome of a component–
compound interaction typically resides with the biomimetic
component or process; in some cases more than one
component or process can be involved. An important feature
of the synthetic approach from a biopharmaceutical sciences
perspective is that each mobile object carries with it all the
information that the empowered (active) component, a
membrane transporter object for example, needs in order to
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adjust and reparameterize its interaction logic. That informa-
tion can include (or not) selected PCPs that domain experts
understand intuitively (molecular weight, logP, measures of
ionization state, etc.) along with bioactivity attributes (the
chemical entity is a CYP 2C9 substrate, etc.). In that way, during
a simulation an analogue system can accommodate objects
representing any number of compounds, which of course is
ideal for studying and exploring drug–drug interactions (63–
65). A component empowered to interact can use compound
identiﬁcation information to adjust its engagement logic.
Early in an analogue’s development, micro-mechanistic
knowledge is insufﬁcient to parameterize component–com-
pound interactions a priori using compound-speciﬁc informa-
tion. Micro-mechanism logic must be tuned individually for
each of the ﬁrst few compounds for which referent data are
available. As the set of compounds enlarges, inductive model-
ing methods within the analogue’s larger framework can be
used, as in (66,67), to establish quantitative mappings from
patterns in chemical entity information to patterns in parameter
values of tuned component–compound interaction. Such a
mapping will be the analogue’s counterpart to a structure-
activity relationship. In subsequent rounds of analogue use and
reﬁnement, the new knowledge contained in that relationship
can be used, in some cases automatically, to provide an initial
analogue parameterization for the next chemical entity to be
studied. Simulations using those parameterizations will stand as
crude predictions of the new compound’s targeted attributes.
The limited (artiﬁcial) intelligence available to analogue
components at that stage can be improved systematically as
the analogue is iteratively validated against wet-lab data for
additional compounds. That primitive intelligence can be
shared between different analogues and models within an
organization’s larger M&S framework.
Each type of component–compound interaction is a
micro-mechanism. The micro-phenomenon that results is
typically simple: transport occurred (or not), metabolism
occurred (or not), spatial relocation occurred (or not), etc.
When such phenomena are studied in vitro in simple systems,
one often observes that just a few molecular descriptors
account for the majority of the data variance for the
compounds studied. Even when the more complex ADMET
properties are analyzed collectively, simple, interpretable
rules of thumb emerge (68). Given the simple and stochastic
nature of most synthetic micro-mechanisms, a small change in
the PCP space can correspond to a negligible or modest
change in the micro-phenomenon, as well as the parameter-
ization of its logic. Computationally simple methods are
expected to sufﬁce in predicting acceptable, micro-mechanism
parameter values. The precision of estimated micro-mecha-
nism parameterizations can be expected to vary randomly
across the analogue. Nevertheless, the predicted, systemic
target phenomena can still be accurate enough for R&D
decision-making; see (67) for an example.
ANALOGUES: FROM IN VITRO TISSUES
TO INTERACTING ORGANS
The evolution of object- and agent-oriented biological
system models over the past decade is interesting but outside
the scope of this article. Currently, there are no analogues
that bridge the gap in Fig. 1. Analogues capable of beginning
to bridge the gap began appearing only recently. Because
model use has been different in each case, a straightforward
comparison of what those different models do (or do not do)
and how they do it would be misleading. Rather, the objective
here is to provide examples of analogues that can evolve to
become gap-spanning, scientiﬁcally useful in silico systems.
We sought examples that would enable readers to envision
analogues that could be useful within their own R&D
domains. With that in mind, we limited examples to those
that included drugs (one case) or to which objects represent-
ing drugs could be added (three cases) without requiring
system reengineering. Because this ﬁeld is relatively new, all
four examples are early stage and still somewhat abstract.
However, it is easy to imagine variants of each, in parallel,
becoming incrementally more sophisticated and realistic.
Filling the Need for an Epithelial Cell Culture Analogue
That Has Its Own Phenotype and Plausible
Operating Principles
Even though their phenotypes are complex, in vitro cell
cultures are among the simplest biological systems. Early
examples of in silico explorations into mechanisms in vitro
using CA and CPMs include (14,69,70). Thereafter, exper-
imentation with agent-oriented methods increased. Within
the past three years, considerable progress has been made
improving in vitro mechanistic insight using primarily more
sophisticated, cell-centered (71), and agent-oriented methods
(53,64,72–77), including exploration of events in a crowded
virtual cytoplasm (78). See Supplemental Material for a
thorough listing of research progress that used variations of
the synthetic method during the intervening years.
There are several agent-based, cell-centered, synthetic
analogues to which drug objects could be added. Walker et al.
(79) provide an early example representing cell–cell mecha-
nisms of interaction using a synthetic, agent-based approach.
Bindschadler and McGrath (72) achieved new insight into
mechanisms of wound healing using an agent-based approach
in which components were grounded purposefully to metric
spaces, enabling direct comparison of simulated and wet-lab
measurements. Zhang et al. (80) developed a sophisticated,
3D, multi-scale, agent-oriented analogue of solid tumor
growth in which agent logic was controlled in part by
conceptualizations of molecular details and gene-protein
interaction proﬁles. Key features were grounded to metric
spaces. The example that follows, even though drawn from
our own work, was selected because the system uses rela-
tional grounding (discussed in “How a Model is Grounded
Impacts How It Can and Should be Used”).
The analogue is a simple synthetic analogue of human
alveolar type II (AT II) epithelial cell cultures (81) similar to
those used in drug discovery and development research (82–
84), where selected system attributes are measured in the
presence and absence of compounds of interest. Below, the
discussion focuses on attributes in the absence of compounds.
The targeted attributes are aspects of AT II cystogenesis in
3D matrix, which recapitulates several basic features of
mammalian epithelial morphogenesis (85). To gain insight
into the process, Kim et al. (81) created a concrete, stand-
alone, in silico “cultured cell” system that had its own unique
phenotype. The system was then reﬁned iteratively so that its
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phenotype had the relationship to in vitro cell phenotypes
that is illustrated in Fig. 3. A case was made that when
mappings from in silico components and interactions to their
biological counterparts are intuitive and clear, even if
abstract, then one can hypothesize that the causal events in
silico have in vitro counterparts. Accepting the reasonable-
ness of these mappings enabled making an important, addi-
tional claim: a mapping will also exist between in silico
operating principles and cellular operating principles.
Representing an Epithelial Cell Culture as a Dynamic System
of Coarse-Grained, Interacting Components
Detailed descriptions and methods are available in
(81,86). Building blocks and their functions, along with
assembly methods were proposed so that components and
the assembled analogue mapped logically to wet-lab counter-
parts. Data accumulated during executions were compared
against referent wet-lab data. When the analogue failed
validation, it was revised and tested iteratively until pre-
speciﬁed behaviors were achieved. The assembled compo-
nents and their operating methods stood as a hypothesis: these
mechanisms will produce targeted characteristics. Execution
and analysis of results tested that hypothesis. Hereafter, to
clearly distinguish in silico components and processes from
corresponding wet-lab structures and processes, we use SMALL
CAPS when referring to the in silico counterparts.
To produce the epithelial cell analogue, a cell culture was
conceptually abstracted into four components. Cells, matrix
(media containing matrix), free space (matrix-free media),
and a space to contain them had in silico counterparts: CELL,
MATRIX, FREE SPACE, and CULTURE. MATRIX and FREE SPACE
were passive objects. MATRIX mapped to a cell-sized volume
of extracellular matrix. A FREE SPACE mapped to a similarly
sized volume that was essentially free of cells and matrix
elements. Cells were quasi-autonomous agents, which mim-
icked speciﬁed behaviors of AT II cells in cultures. Each used
a set of rules or decision logic to interact with their local
environment. When two or more CELLS attached, they acted
quasi-autonomously, independent of individual CELL activ-
ities. The CULTURE used a standard 2D hexagonal grid to
provide the space in which its objects resided and moved
about. The simulation was executed in discrete time steps,
during which each CELL, in pseudo-random order, took
actions based on its internal state and external environment.
Having objects update pseudo-randomly simulated the paral-
lel operation of cells in culture and the nondeterminism
fundamental to living systems, while building in a controllable
degree of uncertainty.
The initial list of targeted attributes was obtained from in
vitro studies of primary human AT II cells (85). Observations
determined that there was neither cell death nor prolifer-
ation. Achieving the targeted attributes (Fig. 5) required just
three action options: migrate, attach to an adjacent CELL, or
rearrange within a CLUSTER (Fig. 4B). Cells required three
types of migration, separately or in pairs: random movement,
CHEMOTAXIS, and CELL density-based migration. A CELL could
switch its migration mode during execution. The CELL–CELL
attachment action executed when two CELLS were in contact.
CELL rearrangements within a CLUSTER were speciﬁed using
axiomatic operating principles (81).
Fig. 4. AT II analogue design and CELL logic. A Shown is the AT II
analogue design from (81). A hexagonal grid provides the space
within which the four components interact. Cells are quasi-autono-
mous agents, which mimic AT II cell behaviors in vitro. Diffuser is a
space to simulate diffusion of an abstract factor used to guide
CHEMOTAXIS. The system-level components included EXPERIMENT
MANAGER (the top-level system agent), OBSERVER (recorded measure-
ments), and CULTURE graphical user interface (GUI). B Simulation
time advances in steps corresponding to simulation cycles. Each
simulation cycle maps to an identical interval of wet-lab time; during
a cycle, every CULTURE component is given an opportunity to update.
Every CELL, selected randomly, decides what action to take based on
its internal state (clustered or single) and the composition of its
adjacent neighborhood. Enabled CELL actions are CELL–CELL attach-
ment, CELL migration, and rearrangement within a CLUSTER. A CELL
within a CLUSTER can rearrange with other CELLS composing the
CLUSTER, driven by a set of axiomatic operating principles (see (81)
for speciﬁcs).
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Hypothesizing and Testing Plausible Mechanisms of AT II
Cystogenesis
A sequence of increasingly stringent Similarity Measures
(SMs) was used for validation and analogue reﬁnement (81).
So doing allowed discovery of constraints and mechanism
changes (including logic adjustments or changes) that moved
the analogue’s behavior space (phenotype) toward targets
and thereafter shrank it. Initially, every CELL was in a single,
non-clustered state. As the simulation progressed, CELLS
produced CULTURE level behaviors that qualitatively and
quantitatively matched those observed in vitro (Fig. 5).
Migrating single CELLS formed CELL–CELL attachments, which
led to formation of small CLUSTERS. Some CLUSTERS migrated
and merged with CELLS and other aggregates to form larger
CLUSTERS. Cells within CLUSTERS rearranged themselves into
conﬁgurations dictated by the axioms, causing adequately
sized CLUSTERS to develop progressively into alveolar-like
CYSTS (ALCS) having FREE SPACE surrounded by a CELL
monolayer. ALCS maintained convexity and had no dimples;
most remained stable until the simulation terminated. Note
that a structure having a regular hexagonal shape in
hexagonal grid space maps to a circle in continuous space.
For AT II CYSTOGENESIS, CELL activity patterns during
simulations made clear how their mandates, the targeted
attributes, are achieved. That clarity provided insight into and
plausible explanations of AT II cystogenesis in vitro.
In vitro, the average ALC size increased monotonically
with initial cell density. Similar patterns were observed during
simulations: mean values and their standard deviations are
graphed in Fig. 5A. In sparse CULTURES with < 1,000 CELLS,
which mapped to ∼1×104 cells/cm2 in vitro, CELLS formed
small ALCS with diameters that were essentially the same as
the referent mean diameter. In denser CULTURES, larger ALC
diameters were observed. Changes in the number of clusters,
as a function of initial cell density, were the same for both in
vitro and in simulations (Fig. 5B). AT II cell migration speed
was an important determinant of aggregation and ALC
formation in 3D cultures. Intuitively, one would expect to
achieve the production of larger ALCs by elevating cell
speed. Doing so would increase the cell collision rate and thus
accelerate aggregation. Conducting such experiments in vitro
Fig. 5. AT II analogues and AT II cell cultures can exhibit quantitatively similar, phenotypic attributes. A Mean ALC
diameters, both in silico and wet-lab, are graphed as a function of initial cell density. Open circles: mean in vitro diameter
after 5.7 days; vertical bars: ±1 SD (n=25). Filled circles: mean analogue diameters after 100 simulation cycles (∼6.1 days);
bars: ±1 SD (n=100). The dominant migration mode was CELL density-based. At initial densities of ≤ 2,000 CELLS 10–15% of
CELLS moved randomly; at higher initial densities, movement was CELL density-based. B Open circles: ﬁnal, mean cluster
count (averaged over three culture wells) for the in vitro experiments in A. Filled circles: ﬁnal mean CLUSTER count in A. C
Phase-contrast pictures after 4 d in 2% Matrigel. Bar: ∼50 µm. D A sample image of simulated culture after 100 simulation
cycles starting with 2,000 CELLS. Note that a hexagonal CYST within the discretized hexagonal space maps to a roundish cross-
section through an ALC in vitro. Objects with white centers are CELLS. Gray and black spaces represent MATRIX and FREE (or
LUMINAL) SPACE, respectively. E Shown are the consequences of changing CELL speed CELL in density-based mode. Speed
(circled) is in grid units per simulation cycle; CELLS in A–D migrated 1 grid unit/cycle. Values are based on 100 Monte Carlo
runs for 100 simulation cycles. The arrow pointing down shows the observed change in mean ALC diameter at the indicated
initial cell density when Matrigel density was increased from 2% to 10%. Images adapted from (81).
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is infeasible because a minimum level of extracellular matrix is
required to sustain normal AT II cell behaviors. Testing that
hypothesis for AT II analogues was straightforward and
achieved by parametrically changing CELL migration speed.
Slowing migration speed was expected to correlate to
increased extracellular matrix densities. As shown in Fig. 5E,
the results predicted a dramatic reduction in ALC formation
when the extracellular matrix is stiffened. The prediction was
tested and conﬁrmed in vitro at a high initial cell density (85).
Simulating Tissue Responses In Vivo
Achieving Micro-mechanistic Insight to Ischemic
Microvascular Injury
The work by Bailey et al. (87) demonstrates the potential
of using synthetic models for hypothesis generation and
knowledge discovery, and is also an excellent example of
multiple iterative cycles of in silico experimentation coupled
with wet-lab experimentation. They constructed a multi-cell,
tissue-level, agent-oriented model of human adipose-derived
stromal cell (hASC) trafﬁcking through the microvasculature
of skeletal muscle tissue after acute ischemia.
After ischemic injury to microvasculature, blood is re-
routed to adjacent microvascular networks causing swelling
and increases in wall shear stress and hydrostatic pressures at
the adjacent site. The changes in wall shear stress and
circumferential stress activate endothelial cells and perivas-
cular cells, initiating the recruitment of circulating cells into
the site of injury. Activated endothelial cells increase their
surface expression of important cellular adhesion molecules
that enable the circulating cells to home to the site of ischemic
injury, adhere to the endothelium, extravasate, and incorpo-
rate into the injured tissue. In addition, activated endothelial
cells and perivascular cells secrete a number of inﬂammatory
chemokines, cytokines, and growth factors. These further
activate endothelial and perivascular cells, as well as activat-
ing circulating cells in order to promote their recruitment into
the site of ischemic injury. Intravenous delivery of hASC has
been shown to help repair and regenerate injured tissue from
ischemia. An analogue was used to gain mechanistic insight
into that process.
Bailey et al. constructed an agent-based model to identify
potential bottlenecks that may limit the efﬁciency of these
therapeutic cells being recruited into the site of ischemic
injury after intravenous injection. It was their hope that better
clinical outcomes could be achieved through increasing the
number of incorporated hASCs.
They used confocal immunohistochemistry images to
manually reconstruct in silico the morphology of a character-
istic microvascular network (Fig. 6). The endothelial cells
lining the vessel surface, tissue resident macrophages, circu-
lating monocytes, and therapeutically delivered stem cells were
represented as individual software agents. The agent-based
model was coupled with a network blood ﬂow analysis program
that calculated blood pressure, ﬂow velocities, and shear
stresses throughout the simulated microvascular network.
Individual in silico CELL behaviors were determined from
a set of over 150 rules that were derived from independent
literature. Each ENDOTHELIAL CELL, MONOCYTE, and HASC
could, in a binary manner, either be positive or negative in
their expression of each CELLULAR ADHESION MOLECULE. In a
similar binary manner, each ENDOTHELIAL CELL, MONOCYTE,
and TISSUE resident MACROPHAGE could either be in a positive
or negative state of secretion for each of the CHEMOKINES and
CYTOKINES. Thus, each CELL could be unique. A CELL’S state
of CELLULAR ADHESION MOLECULE expression and state of
CHEMOKINE and CYTOKINE SECRETION were also dynamic, and
depended upon the CHEMOKINE and CYTOKINE SECRETION
states of neighboring CELLS (Fig. 6D).
Whether a circulating MONOCYTE or HASC rolled or
adhered was dependent on a combination of factors. They
had to experience the correct combination of CELLULAR
ADHESION MOLECULE expression states and CHEMOKINE
SECRETION states from a nearby ENDOTHELIAL CELL, and have
also experienced a WALL SHEAR STRESS below a certain
threshold level. If the CELL adhered for more than a speciﬁed
number of time steps, it could then TRANSMIGRATE into the
TISSUE space.
Bailey et al. simulated a microvascular network under
normal conditions and after ischemic injury. The MICROVAS-
CULAR network was representative of a microvascular net-
work adjacent to the site of ischemic injury, where blood ﬂow
is increased due to its redistribution. When simulating
ischemic injury, the PRESSURE at the feeding ARTERIOLE was
increased by 25% and the resultant HEMODYNAMIC properties
were re-calculated.
Simulation Experiments Implicated an Additional Cellular
Adhesion Molecule
The analogue was veriﬁed without HASC by performing a
series of in silico knockout experiments, comparing simulated
and wet-lab phenomena where data were available, and by
showing that the analogue could mimic three aspects of
ischemic injury: (1) increase in wall shear stress and network
rates; (2) up-regulation of speciﬁc cellular adhesion molecules
expression by the endothelium; and (3) increased secretion
levels of chemokines and cytokines. Additionally, two key
monocyte properties had in silico counterparts. Following
veriﬁcation, they simulated hASC trafﬁcking after INTRA-
VENOUS injection before and after ISCHEMIC injury. Lower
than expected levels of HASC EXTRAVASATION were observed,
and that led to a re-evaluation of their rule-set. hASCs do not
express PSGL-1, however they hypothesized that there may
exist an additional cellular adhesion molecule used for rolling,
similar to PSGL-1, for which there was no counterpart in
their analogue.
To explore that hypothesis, they included an additional
CELLULAR ADHESION MOLECULE, termed SBM-X, with
properties similar to PSGL-1 and determined whether so
doing allowed the analogue to more closely mimic in vivo
experimental results. Simulations showed that the inclusion
of the new MOLECULE SBM-X was necessary to achieve
targeted levels of HASC EXTRAVASATION. They subsequently
tested their hypothesis in vitro and showed that small
fractions of hASCs are able to roll on P-selectin even
though they do not express PSGL-1. They proposed that
the cellular adhesion molecule CD24 is a likely SBM-X
candidate.
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In Silico Livers
An In Silico Liver is Constructed by Assembling Simple
Components into a Larger, Multi-Level, Biomimetic Structure
In Silico Livers (ISLs) are advanced examples of
biomimetic analogues designed speciﬁcally to help bridge
the gap in Fig. 1. An ISL is not intended to be a model having
a temporally stable structure. It is designed to be altered
easily in order to explore many equally plausible mechanistic
explanations for disposition-related observations. The ISL is
an assembly of componentized mechanisms: purposefully
separated and abstracted aspects of hepatic form, space, and
organization interacting with COMPOUNDS. Each component
mechanism has been unraveled from the complex whole of
the hepatic-drug phenotype; it has its own unique phenotype,
but that phenotype is much simpler than that of the entire
lobule mechanism.
ISL-targeted attributes were divided into three classes
(88): 1) compound-speciﬁc time course data, 2) microana-
tomical details (heterogeneous sinusoid structures, perive-
nous cross-connections between sinusoids, etc.), and 3)
experiment details (perfusion is single-pass or not, adminis-
tered compounds pass though catheters and large vessels
before entering lobular portal vein tracts, etc.). A primary use
has been to use and reuse similar ISL structures to provide
plausible micro-mechanistic explanations of hepatic disposi-
tion data for many drugs.
An ISL maps to a mammalian liver undergoing perfusion
as in (89). It is physiologically based, yet abstract. An ISL
represents a liver as a large, parallel collection of similar
lobules (Fig. 7A). An ISL’s functional unit is the same as the
liver’s: a lobule. Lobule structure is illustrated in Fig. 7B–D
and detailed in (88,90,91). The following is an abridged
description. Components mimic essential form and function
features of a rat liver. Acinar ﬂow patterns are represented by
an interconnected, directed graph (Fig. 7B). Graph edges
specify ﬂow connections between objects called Sinusoidal
Segments (SS). An SS, which maps to a unit of sinusoid
function, is placed at each graph node. Multiple, different
ﬂow paths from portal vein tracts (PV) to central vein (CV)
are present, as illustrated in Fig. 7B.
The SS structure shown in Fig. 7C maps to a unit of
sinusoid function that includes spatial features. An SS is a
Fig. 6. Simulated human, adipose-derived, stromal cell (hASC) trafﬁcking through the microvasculature during acute skeletal muscle ischemia
(adapted from (87) with permission). The referent for the MICROVASCULAR NETWORK was skeletal muscle visualized using confocal microscopy
following harvest, using a 20× objective. A Confocal microscopy image of mouse spinotrapezius muscle immuno-stained to visualize epithelial
cells having BS1-lectin antibody (white). Vascular structures of interest were copied (yellow). Arterioles and venules were characterized based
on vessel diameter. Scale bar: 1 mm. B The network in A was manually discretized into nodes (bifurcation points, marked red). Nodes were
connected to form elements. C Screen-shot of simulation space. Nodes and elements were manually constructed within a NetLogo simulation
space to mimic the referent network in A. Red SMOOTH MUSCLE CELLS line ARTERIOLES and VENULES. Simulated hASHs that have successfully
EXTRAVASATED are green, otherwise they are white. ENDOTHELIAL CELLS are yellow; TISSUE MACROPHAGES present within the INTERSTITUM are
blue. D Illustration of the complex and dynamic connections between the four CELL types. The listed, referent chemokines and cytokines have
all been implicated in human ischemic injury. Arrows indicate connections between CELL populations and denote some combination of the
following: induced SECRETION, changes in CELLULAR ADHESION MOLECULE expression, and/or INTEGRIN activation. All connections between
nodes were based on relevant, independent, experimental literature. Images are adapted from (87).
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discretized, tube-like structure comprised of a BLOOD “core”
surrounded by three identically sized 2D grids, which
together simulate a 3D structure. It can be replaced by more
realistic 3D grid when it is required to do so to achieve some
targeted attribute. Two SS classes, S1 and S2, are speciﬁed to
provide sufﬁcient variety of COMPOUND travel paths. Com-
pared to an S2, an S1 on average has a shorter internal path
length and a smaller surface-to-volume ratio.
ISL parameters are grouped into three categories: 1)
those that control LOBULE graph and 2) SS structures, and 3)
those that control LOBULAR component interactions with
COMPOUNDS. Compounds are represented using objects that
move through the LOBULE and interact with encountered SS
features. A typical COMPOUND maps to many drug molecules
(see Representing Compounds in the Appendix). A COM-
POUND’S behavior is determined by the PCPs of its referent
compound, along with the LOBULE and SS features encoun-
tered during its unique trek from PV to CV. During a
simulation cycle, an encountered component “reads” the
information carried by a COMPOUND and then uses it to
customize its response, in compliance with its parameter
values, following some pre-speciﬁed logic. That feature
enables multiple, different COMPOUNDS to be percolating
through SS features during the same experiment.
Objects called CELLS (Fig. 7D) map to an unspeciﬁed
number of cells. They function as containers for other objects.
A grid location and its container are the current limit of
spatial resolution. Cells contain a stochastic parameter-
controlled number of BINDERS in a well-stirred space. Binders
map to transporters, enzymes, lysosomes, and other cellular
material that binds or sequesters drug molecules. In the cited
work, a BINDER within an ENDOTHELIAL CELL only bound and
later released a COMPOUND. A BINDER within a HEPATOCYTE is
called an ENZYME because it can bind a substrate COMPOUND
and either release or METABOLIZE it. Additional objects can
be added as needed, as in (65), to represent uptake and efﬂux
transporters, specialized enzymes, and pharmacological tar-
gets, without compromising function of objects already
Fig. 7. Illustrated are hepatic lobular structures and their ISL counterparts. A A schematic of a
cross-section of a hepatic lobule showing the direction of ﬂow from the terminal protal vein tracts
(PV) through sinusoids in three concentric zones to the central hepatic vein (CV). Different zones
can have quantitative differences in structural and functional characteristics. B A portion of the
SINUSOID NETWORK is shown. It is an interconnected, three-zone, directed graph (lines connecting
shown as circles). It maps to a portion of a lobular sinusoid network. Data from the literature are
used to constrain the graph size and structure. Circles: sinusoidal segments (SS). C A schematic of a
sinusoidal segment (SS): one SS occupies each node speciﬁed by the directed graph (in Fig. 7B).
Grids map to hepatocyte spaces; they contain objects that map to intracellular functionality. From
Grid A, they can access the other spaces. Grid locations have properties and that govern their
interaction with mobile COMPOUNDS. Different shadings of Grid A illustrate the potential for
representing heterogeneous properties. Objects functioning as containers (for other objects) map to
cells, and can be assigned to any grid location. D Shown are ENDOTHELIAL CELL and HEPATOCYTE.
Objects representing all needed intracellular features can be placed within. Two types of
intracellular BINDERS recognize COMPOUNDS: those that simply bind (BINDER) and those that also
map to enzymes and can METABOLIZE. Bile attributes can be represented easily when needed.
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present. Because of the stochastic nature of ISL simulations,
each in silico experiment generates a slightly different outﬂow
proﬁle.
Experimenting on ISLs to Better Understand
Micro-mechanisms and Predict Hepatic Drug Disposition
In (90), a single parameterized ISL structure was arrived
at iteratively, and held constant for antipyrine, atenolol,
labetalol, diltiazem, and sucrose. Parameters sensitive to
compound-speciﬁc PCPs were tuned so that ISL outﬂow
proﬁles were validated separately and together against rat
perfused liver outﬂow proﬁles. Each ISL component inter-
acted uniquely with each of the ﬁve compounds. The
consequences of ISL parameter changes on outﬂow proﬁles
were explored. Selected changes altered outﬂow proﬁles in
ways consistent with knowledge of hepatic anatomy and
physiology and compound PCPs. That level of validation
enabled the authors to posit that static and dynamic ISL
micro-mechanistic details, although abstract, mapped realisti-
cally to hepatic mechanistic details. Because ISL mechanisms
are built from ﬁner-grained components, there is precise
control over conﬂation. The causal basis is present in the
component–COMPOUND interaction logic (axioms, rules). An
expectation has been that at some level of granularity, the
complexity will be sufﬁciently unraveled so that the logic for a
given micro-mechanism (its “causal basis”) will rely heavily
on only a few easily speciﬁed COMPOUND and biological
attributes.
Subsequently, in (91), quantitative mappings were estab-
lished between drug PCPs and ISL parameter values for the
above four sets of drug PCPs and the corresponding sets of
PCP-sensitive, ISL parameter values. Those relationships
were then used to predict PCP-sensitive, ISL parameter
values for PRAZOSIN and PROPRANOLOL given only their PCPs.
Relationships were established using three different methods:
1) a simple linear correlation method, 2) the Fuzzy c-Means
algorithm, and 3) a simple artiﬁcial neural network. Each
relationship was used separately to predict ISL parameter
values for PRAZOSIN and PROPRANOLOL given their PCPs.
Those values were then used to predict disposition details for
the two drugs. All predicted disposition proﬁles were judged
reasonable (well within a factor of two of referent proﬁle
data). The parameter values predicted using the artiﬁcial
neural network gave the most precise results. More note-
worthy, however, was that the simple linear correlation
method did surprisingly well. That is because the ISL is an
assembly of micro-mechanisms where each is inﬂuenced most
by a small subset of PCPs. The results suggest that when using
the synthetic method of assembling separated micro-mecha-
nism, a parameter estimation method, which reasonably
quantiﬁes the relative differences between compound-speciﬁc
behaviors at the level of detail represented by those micro-
mechanisms, will provide useful, ballpark estimates of hepatic
disposition. That bodes well for using synthetic analogues for
predicting PK properties, given only molecular structure
information.
Starting with the ISLs described above, Park et al. (21)
discovered that they could alter a small subset of ISL parameter
values, tuned previously to match diltiazem’s outﬂow proﬁle,
and match diltiazem’s outﬂow proﬁle from a diseased rather
than a normal rat liver (Fig. 8). Dynamic tracing features
enabled spatiotemporal tracing of differences in dispositional
micro-mechanisms. Differences in ISL attributes mapped to
measures of histopathology. By measuring disease-caused
differences in local, INTRALOBULAR and within-zone effects
(Fig. 9), they obtained heretofore-unavailable views of how and
where hepatic drug disposition may differ in normal and
diseased rat livers from diltiazem’s perspective. The approach
and technology represent an important step toward unraveling
the complex changes from normal to disease states and their
inﬂuences on drug disposition.
Because the causal, mechanistic differences occur at the
micro-mechanism level, it is easy to morph—transform—a
NORMAL ISL into a DISEASED ISL (Fig. 8B). The morphing
stands as a hypothesis for how and where disease may have
altered hepatic micro-architectural features and processes.
Fig. 8. ISL properties. A Outﬂow proﬁles of NORMAL and DISEASED
ISLs are compared. Values are smoothed, mean DILTIAZEM levels
(fraction of dose per collection interval) from the NORMAL and
DISEASED ISL that achieved the most stringent, pre-speciﬁed Sim-
ilarity Measure: >90% of simulated outﬂow were within a factor of
0.33 of corresponding wet-lab values. B Illustrated is a simple
example of the model-to-model translational mapping mentioned in
the “Introduction.” Eleven of 25 key ISL parameters’ values that
were tuned to create the DILTIAZEM outﬂow proﬁle from a NORMAL
LIVER were altered to obtain the validated DILTIAZEM outﬂow proﬁle
from a DISEASED LIVER. Three of the 11 were LIVER structure
parameters. Their change mapped to disease-caused changes in
referent liver micro-anatomical characteristics. Nine of the eleven
were parameters governing movement and interaction of DILTIAZEM
with LIVER components, such as moving between spaces and the
probability of METABOLISM after being bound to an ENZYME. For the
attributes targeted, intermediate ISL parameterizations (of those 11)
can be used to document the incremental transformation of a
NORMAL to a DISEASED LIVER. The details of such a transformation
provide a working, abstract hypothesis for the mechanisms of actual
disease progression; they specify what must be changed (morphed) to
translate results from one wet-lab model to another.
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The transformation methods are generalizable. For example,
a validated analogue of one in vitro cell culture system can be
morphed into a different analogue representing a second in
vitro cell culture system (and vice versa). The process will
present a dynamic hypothesis of where and how COMPOUND
interaction properties differ between analogues.
It is impractical to obtain liver perfusion data for large
numbers of compounds. However, in vitro disposition proper-
ties can be measured using cultured hepatocytes and other
cell types. An advantage of the componentized analogue
approach is that an ISL validated for several compounds can
be re-used to obtain ballpark estimates of hepatic disposition
properties of other compounds by using in vitro data and
taking advantage of ISL component replacement capabilities.
Sheikh-Bahaei et al. (66) validated HEPATOCYTE monolayers
for four different compounds. The referent system was
hepatocytes in a sandwich-culture system that enabled
estimating biliary excretion. Their HEPATOCYTES were based
on the same container object concept used to create ISL
HEPATOCYTES. That similarity opens the door to unplugging
the HEPATOCYTES from an ISL that has been validated for
several compounds and replacing them with HEPATOCYTES
that have been tuned and validated in vitro for one or more
other compounds for which no liver perfusion data is (or will
be) available. Following adjustments based on cross-model
validation studies, the outﬂow proﬁle from such an ISL, given
the new compound’s PCPs, will stand as a ballpark prediction
of that drug’s hepatic disposition.
An Analogue of Interacting Organs
Unraveling the Mechanisms of Systemic Inflammatory
Response Syndrome and Multiple Organ Failure
Gary An (18) engineered a multi-level, two-organ
analogue (gut and lung) to explore plausible causal mecha-
nisms responsible for the clinical manifestation of multi-scale
disordered acute inﬂammation, termed systemic inﬂamma-
tory response syndrome (SIRS) and multiple organ failure
(MOF), and how they may respond to therapeutic interven-
tions (92). Following iterative reﬁnement and parameter
tuning, An discovered course-grained, multi-level analogue
mechanisms that achieved several targeted attributes related
to SIRS and MOF. Simulations used abstract and discrete
analogues of gut and lung, each comprising ﬁxed cell-mimetic
agents forming ENDOTHELIAL and EPITHELIAL TISSUES, mobile
cell-mimetic agents corresponding to inﬂammatory cells, and
mobile objects that mapped to pro-inﬂammatory mediators.
Although exploration of the consequences of drug interven-
tions was not part of the latest study, system design enables
adding drug-mimetic objects when the need arises.
Component interactions have biological counterparts
that extend from intracellular mechanisms to clinically
observed phenomena in the intensive care setting. Different
types of CELL agents encapsulate speciﬁc mechanistic knowl-
edge extracted from in vitro experiments. The model was
used to explore the likelihood of the two prevailing hypoth-
eses about the nature of disordered systemic inﬂammation:
that it is a disease of the endothelium or that it is a disease of
epithelial barrier function. The former paradigm points to the
endothelial surface as the primary communication and
interaction surface between the body’s tissues and the blood,
which carries inﬂammatory cells and mediators. However,
there is also compelling evidence that organ dysfunction
related to inﬂammation is primarily manifest in a failure of
epithelial barrier function. An’s multi-level analogue of
interacting gut and lung enabled exploration of plausible
mechanisms that unify those two hypotheses. Simulations
produced qualitative phenomena that mimicked attributes of
multi-organ failure: severe inﬂammatory insult to one organ
led to both organs failing together.
Abstract, Coarse-Grained Representation of Epithelial
and Endothelial Tissues Responding to INFLAMMATION
The 3D two-ORGAN system was comprised of the six
layered, 2D spaces (square grids) shown in Fig. 10. Greater
detail was not needed for the attributes targeted. Together
they formed the GUT–LUNG axis. From bottom they are Z=0,
1, 2... 5. Different CELL types populated each 2D grid. The
bottom three layers formed the GUT; the top three formed the
LUNG. The two ORGANS shared the same design (92,93): a
layer of EPITHELIAL CELLS on the top (Z=2 & 5) and a layer
of ENDOTHELIAL CELLS in the middle (Z=1 & 4). The bottom
layer of each ORGAN (Z=0 & 3) was a space for mobile
INFLAMMATORY CELLS, CYTOKINES, etc. Cells in each layer
were able to inﬂuence the state of CELLS in the layers above
and below.
In deference to the parsimony guideline, each ORGAN
was composed of an EPITHELIAL surface, which determined
Fig. 9. Temporal changes within comparable ISL micro-mechanisms.
Dispositional events within an ISL from a variety of perspectives can
be measured following dosing. Doing so gives an unprecedented view
of plausible dispositional detail. Examples included measuring BOUND
and UNBOUND DILTIAZEM within HEPATOCYTES, number of METABOLIC
events occurring within any one of the three Zones, or the fraction of
DOSE within a particular SINUSOIDAL SEGMENT (SS). The values
graphed include the latter. Values graphed in A–D are the amounts
of DILTIAZEM in four different states: BOUND and UNBOUND in
HEPATOCYTES, and BOUND and UNBOUND in ENDOTHELIAL CELLS. A
and B: a NORMAL LIVER; C and D: a DISEASED LIVER; A and C: the
focus is SS #14 in Zone 1; B and D: the focus is SS #33 in Zone 3.
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ORGAN integrity, and an ENDOTHELIAL/BLOOD interface, which
provided for initiation and propagation of INFLAMMATION.
The EPITHELIAL CELL layer was validated separately against
data from in vitro cell monolayer models used to study
epithelial barrier permeability. The EPITHELIAL CELL layer
was concatenated with the ENDOTHELIAL/INFLAMMATORY
CELL layers to produce an abstract, coarse-grained gut
analogue. It was separately validated against observations
made on in vivo wet-lab models of the inﬂammatory response
of the gut to ischemia. Finally, the GUT ORGAN and a similarly
constructed PULMONARY ORGAN were combined to create a
gut-pulmonary axis analogue, the behavior of which was
expected to map to in vivo and clinical observations on the
crosstalk between these two organ systems.
The interaction of a layer of ENDOTHELIAL CELLS with a
population of different INFLAMMATORY CELLS was described
in (92,93). The latter included NEUTROPHILS, MONOCYTES, T-
CELLS, etc. All CELLS were agents. The analogue used objects
that mapped to speciﬁc mediators, including endotoxin,
tumor necrosis factor (TNF), and IL-1. Other objects mapped
Fig. 10. Screenshots of Multi-Bilayer GUT–LUNG Axis (adapted from (18)). All illustrations are from (18)
with permission. A Illustrated is the multiple bilayer topology of the interacting GUT–LUNG system. Letter a:
the PULMONARY bilayer; on top (aqua) is the layer of PULMONARY EPITHELIAL CELLS. Each CELL in this and
the other layers is a separate agent. Below that (red) is the layer of PULMONARY ENDOTHELIAL CELLS. Below
that are spherical INFLAMMATORY CELLS. Letter b: the GUT bilayer; the three, similarly conﬁgured layers are
comprised of the same cell types as above. Top (pink): GUT EPITHELIAL CELLS; middle: (red) GUT
ENDOTHELIAL CELLS; bottom: INFLAMMATORY CELLS. Circulating INFLAMMATORY CELLS move between the
GUT–LUNG bilayers. B Shown is an example of GUT barrier dysfunction. The GUT–LUNG system was run
starting with PNEUMONIA as the initial perturbation. Letter c: the localized INJURY to the PULMONARY bilayer;
letter d: the shaded areas demonstrate areas of the GUT EPITHELIAL layer experiencing impaired TIGHT
JUNCTION PROTEIN METABOLISM due to GUT ISCHEMIA from decreased SYSTEMIC OXYGENATION arising from
PULMONARY EDEMA. C Shown are the effects of GUT ISCHEMIA on PULMONARY OCCLUDIN levels (serving as a
proxy for PULMONARY barrier dysfunction) after 72 h of an experiment that started with sub-lethal ISCHEMIA.
Levels of both CYTOPLASMIC and CELL WALL OCCLUDIN levels reached a nadir at ∼24 h (not shown).
Thereafter recovery progressed as INFLAMMATION subsided. Shades of gray: partially recovered PULMONARY
EPITHELIAL CELLS. D Shown are the PULMONARY effects 72 h into an experiment that started with a lethal
level of ISCHEMIA but also with supplementary OXYGEN to 50% (up from normal level of 21%), which added
to the OXYGEN levels that could be generated by the damaged LUNG. CYTOPLASM and CELLWALL OCCLUDIN
levels dropped to minimal levels by 12 h (not shown). The supplementary OXYGEN blunted the effects of
PULMONARY EDEMA by keeping OXYGEN levels above the ISCHEMIC threshold for ENDOTHELIAL CELL
activation. Consequently, ENDOTHELIAL CELLS survived the interval of most intense INFLAMMATION and that
allowed EPITHELIAL CELLS to begin recovering their TIGHT JUNCTIONS. Letter e: intact ENDOTHELIAL CELL
layer. Letter f: recovering PULMONARY EPITHELIAL CELLS. Letter g: intact and recovering GUT EPITHELIAL
CELLS.
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to receptors, including L-selectin, ICAM, TNF receptors, and
IL-1 receptors. The interaction of those objects mapped to
signals being transferred between inﬂammatory cells and
endothelial cells. The rules and operating principles used by
CELLS were abstract yet strove to reﬂect current knowledge:
positive and negative feedback relationships were imple-
mented using simple arithmetic relationships. Receptor status
was expressed as either on or off. The system enabled
simulating the dynamics of the innate immune response and
exploring plausible mechanisms of systemic inﬂammatory
response syndrome due to a disease of endothelial cells.
EPITHELIAL CELL agents are the smallest functional unit
of the GUT–LUNG analogue. Each agent maps to a single
epithelial cell in the context of its response to inﬂammatory
mediators, including nitric oxide, and pro-inﬂammatory
cytokines, including TNF and IL-1. Any EPITHELIAL CELL
can form a TIGHT JUNCTION with any of its eight EPITHELIAL
CELL neighbors. The process required FUNCTIONAL and
LOCALIZED TIGHT JUNCTION PROTEINS and could be impaired
by INFLAMMATION. That analogue mechanism mapped to the
production and localization of tight junction proteins being
impaired in a pro-inﬂammatory cytokine milieu. The EPITHE-
LIAL component was ﬁrst validated against in vitro data. That
validated component was used directly as its in vivo counter-
part. Variables within each CELL controlled levels of TIGHT
JUNCTION components along with INTRACELLULAR, pro-
INFLAMMATORY signals. The phenomena of pro-inﬂammatory
signals impairing tight junction function, and tight junction
dysfunction leading to epithelial barrier failure were targeted
attributes. Simple rules speciﬁed factor creation and how
those factors interacted. Component levels and rules were
tuned to achieve a satisfactory degree of similarity between
analogue phenomena during simulated treatments and corre-
sponding reported observations. When TIGHT JUNCTION for-
mation was impaired (or its components inhibited), a factor
permeated the EPITHELIAL CELL layer in a process that
mapped to epithelial barrier failure. The same analogue
mechanism was used with LUNG EPITHELIAL CELLS in a process
that mapped to pulmonary edema, impaired oxygenation, and
further injury.
Linking GUT and LUNG Analogues into a Higher Level,
Interacting System of Organs
An inherent property of synthetic system models is
composability (the linkage or establishment of component,
inter-relationships) downward, by nesting components within
components, and laterally, by linking components at a similar
level (linkage of the SS in the ISL is an example). By linking
GUT and LUNG, An demonstrates the important point that
upward composability can yield signiﬁcant beneﬁts—in the
form of improved insight—and was necessary for achieving
the research objective.
For the GUT ORGAN, two coupled phenomena were
targeted: 1) the gut can fail in the presence of severe ischemia,
but 2) it can recover from less severe ischemia. In the GUT,
ISCHEMIA interfered with formation of TIGHT JUNCTION compo-
nents and thus EPITHELIAL barrier function. Each GUT ENDO-
THELIAL CELL had an ISCHEMIC INJURY parameter that enabled
the control of the proportion of ENDOTHELIAL CELLS having
ISCHEMIC INJURY. The latter led to production of a pro-INFLAM-
MATORY signal (called CELL-damage-byproduct). The ENDOTHE-
LIALCOMPONENT for both GUT and LUNG also needed to recover
from perturbations simulating both infectious and non-infec-
tious insult, where the infectious insult replicated and actively
damaged the system. It needed to do so while mimicking
recognized component mechanisms. GUT EPITHELIAL CELLS
responded to that byproduct. The process simulated epithelial
barrier dysfunction. Simulation results are consistent with the
hypothesis that the CELL-damage-byproduct was responsible for
activation of circulating INFLAMMATORY CELLS and that, in turn,
led to ORGAN injury. If we accept the analogue-to-referent
mappings as being reasonable, then there may be an in vivo
counterpart to the CELL-damage-byproduct. The LUNG
employed essentially the same mechanisms. For the LUNG
ORGAN, two coupled phenomena were targeted: epithelial
barrier dysfunction results in lung edema and impaired systemic
oxygenation, and supplemental oxygen can increase the sub-
lethal threshold of hypoxia. Pulmonary EPITHELIAL barrier
dysfunction led to impaired OXYGENATION, which in turn
affected systemic ENDOTHELIAL CELL OXYGENATION status.
For the two\ coupled ORGANS, two attributes were that a
severe inﬂammatory pulmonary insult (such as pneumonia)
can lead to gut failure (Fig. 10B), and gut ischemia can lead to
pulmonary failure (Fig. 10C). Given those, three modes of
ORGAN crosstalk were speciﬁed: 1) INFLAMMATORY CELLS
moved between Z=0 and Z=3 carrying INFLAMMATORY
signals; 2) the CELL-damage-product produced by ISCHEMIC
ENDOTHELIAL CELLS in GUT moved to LUNG where it could
activate LUNG INFLAMMATORY and ENDOTHELIAL CELLS. That
process had a negative impact on ENDOTHELIAL function and
EPITHELIAL barrier function, which, in turn, impacted systemic
OXYGENATION; and 3) all ENDOTHELIAL CELLS were dependent
on a baseline OXYGENATION level. It decreased as LUNG
dysfunction increased. Simulations with the two ORGANS
coupled together showed that a severe insult to one organ
(which, for example, may map to pneumonia) led to MOF:
LUNG INFLAMMATION led to impaired systemic OXYGENATION
and GUT ischemia, which, in turn, fed back to the LUNG,
potentiating PULMONARY dysfunction and lowering the ana-
logue’s sublethal ischemic threshold.
REASONING TYPES AND THEIR DIFFERENT ROLES
IN M&S
Three Types
& Deduction, induction, and abduction play different,
essential roles in M&S.
& Methodical use and documentation of all three
reasoning types is required.
The three methods of reasoning are induction, deduc-
tion, and abduction. For completeness, they are described and
discussed in the Appendix. Conditions supportive of all three
reasoning methods are sketched in Fig. 11A. Traditional
mathematical M&S involves little if any abduction. However,
each of the four example systems in “Analogues: From In
Vitro Tissues to Interacting Organs” was realized following
cycles of abduction, induction, and deduction. The same
iterative, scientiﬁc cycles characterize the discovery and
knowledge generation processes during the early stages of
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biopharmaceutical research; we return to that idea below.
The three types of reasoning contribute differently to the
creation of new knowledge. Consequently, some review is
warranted along with a discussion of where and how best to
use the three reasoning methods to enable scientiﬁc M&S, as
discussed in “M&S and the Scientiﬁc Method.”
A model is a physical, mathematical, or logical represen-
tation of a referent system. The word model shares its
etymological ancestors with the word measure. A model is,
fundamentally, a measurement device or method for some
referent. We use analogue to refer to models that are physical,
such as an in vitro tissue model, and to distinguish products of
the synthetic method from inductive models. An analogue’s
existence, operation, mechanism, etc. are entirely independent
of the modeler and the referent. In those cases where the
analogue consists of a computer running a program, we call it a
simulation. Note that a simulation must be executing—prior to
and after the computer executes the program it is merely a set
of instructions (program) and an instruction interpreter/
executor (computer). Computation is a form of inference or
reasoning: it is deduction. It is noteworthy that biological
processes are also largely deductive, but the challenge is that
biology is a young science; we do not know much about the
language of biological processes or axioms.
In order to understand how computational models are
and should be used for mechanism and knowledge discovery,
one needs to understand how induction, deduction, and
abduction relate to computational M&S. Those relationships
are at the core of both synthetic and scientiﬁc M&S.
Synthetic Analogues Encourage Abductive, Scientific
M&S
& Abductive inference dominates upstream discovery
and development.
& Experimenting on synthetic analogues encourages
abductive inference in exactly the same way as wet-
lab experimentation.
& Abduction, induction, and deduction are necessary
for discovery and development decision-making.
& Scientiﬁc M&S requires designing and conducting
experiments on analogues designed to qualify as
objects of experimentation.
& Multiple competing hypothetical mechanisms (models)
are required.
Models are used throughout the drug development
pipeline from discovery to post-marketing surveillance and
from laboratory production to manufacturing. However,
model purpose and usage vary within that pipeline.
Downstream models focus on achieving some speciﬁc
objective, like documenting that disease progression can
be halted or improving a drug’s supply chain. Upstream,
scientiﬁc models focus on adding new domain knowledge
and reducing uncertainties. We argue that abductive
inference is most important for upstream M&S, and we
will show that experimenting on synthetic analogues
encourages abductive inference in exactly the same way
as wet-lab experimentation.
None of the three methods of reasoning adds new
knowledge on its own. In particular, deduction, being purely
syntactic, is incapable of adding new knowledge. Because
most current computational analogues are, independent of
some larger, descriptive context, deductive devices, it is
justiﬁable to doubt the extent to which such an analogue
can be scientiﬁc. Such an analogue is a statement about what
is currently known or believed. The means for making
computational analogues scientiﬁc lies in model usage and
how that usage ﬁts into the larger research enterprise. The
same is true of a wet-lab model.
New knowledge comes about by seeking and confront-
ing contrast, anomaly, and surprising or unexpected obser-
vations. Our models evolve fastest when they fail to
capture the world around us. When that occurs, we
respond by constructing explanatory hypotheses—often
relying on abduction—which are usually manifold and
typically wrong at ﬁrst. The collection of initial hypotheses
is reﬁned iteratively through rational analysis, including
experimentation and deduction in both the minds of the
Fig. 11. Analogue characteristics. A Conditions supportive of all
three reasoning methods are sketched. Obviously, everyone associ-
ated with a pharmaceutical or biotechnology R&D effort would like
knowledge about all wet-lab research systems to be rich and detailed,
and for uncertainties to be limited. Such conditions (toward the far
right side), which are common in non-biological, physical systems,
favor developing inductive models that are increasingly precise and
predictive. However, the reality is that we are most often on the left
side, where frequent abduction is needed and synthetic M&S methods
can be most useful. B Four different model types are characterized in
terms of robustness to context or referent, as discussed in the text. In
terms of components and variables (input/output), PK/PD models
(like many inductive, equation-based models) and the GUT–LUNG
analogue are abstract enough to represent different families of
referents, whereas the ISL and most PBPK models are more concrete
and so less ﬂexible.
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researchers as well as in computer simulations. Those that
survive are further reﬁned in the face of these newly
induced models. At the end of this iterative process, the
most robust explanatory and predictive hypotheses can be
integrated into larger bodies of theory.
Granted, the above is a caricature of the actual process,
which is extremely complex and social. But from the
perspective presented, it is clear that abduction is very
important to the scientiﬁc method. Scientiﬁc models—in silico
or in the mind of a domain expert—are primarily abductive.
This should be common sense, since science is about
capturing, reﬁning, and ultimately reducing our ignorance of
a given system. As scientists, we deal more with what we do
not know or do not understand than with what we do know or
understand.
Computational analogues differ from other model types
(e.g. in vitro, in situ, in vivo) because they rely entirely on
machinery that has been explicitly and aggressively designed
so that variation, anomaly, and surprise are minimized to the
point where they are vanishingly small. For the most part,
computational analogues are deterministic, well-controlled,
and predictable devices. Because of this special status, the
overwhelmingly popular uses of computational analogues do
not involve experimentation. By contrast, consider an in vitro
model. It is also explicitly and aggressively designed to
minimize variation. However, there are always system
component aspects about which the experimenter is funda-
mentally ignorant. Obviously, that is the component of
interest (cells, tissue explant, etc.). We still treat artiﬁcial
machines as experimental systems, even though well-under-
stood theories are known to govern their behavior. In
contrast, we often believe we fully understand and can
validate computational programs. Most researchers do not
treat a computational analogue as an experimental apparatus.
Instead, we inscribe into them what we expect to
conclude from them. As stated above, that is deduction. The
conclusions are the same as the premises, just transformed by
a formal system grammar. Hence, if we maintain that
computational analogues are completely veriﬁed (we know
precisely what they do) and they are purely deductive (truth-
preserving), then we cannot rely on them as rhetorical devices
in and of themselves without committing the fallacy of petitio
principii—assuming the conclusion. This situation makes it
clear that in order to avoid fallacy, any scientiﬁc rhetoric of
which a computational model is a part must include the other
two types of inference (abduction and induction), and to do
that must draw on additional models, especially those in
the mind of the researcher. That realization implies that
scientiﬁc research involving computational analogues—
scientiﬁc M&S—is characterized by testing multiple sim-
ilarly plausible models, just as abduction requires testing
multiple hypotheses and induction requires multiple obser-
vations. Note that abduction and induction occur at a level
above the computational analogues.
The described framework for the scientiﬁc use of
computational models requires designing and conducting
experiments on the analogue and constructing analogues that
merit being objects of experimentation. Each of the four
biomimetic systems in “Analogues: From In Vitro Tissues to
Interacting Organs” had multiple predecessors (which, at the
time were considered plausible models about some aspect of
phenotype) that were challenged experimentally and found in
some way wanting.
M&S AND THE SCIENTIFIC METHOD
Two Major Categories of Robustness: You Cannot Have
Both
& Inductive models tend to be robust to changes in
referent; synthetic models tend to be robust to
changes in context.
& Synthetic models are more useful early on, while
inductive models are more useful later.
& As they mature, synthetic models will also be useful
later.
For the computational models in Fig. 1, including those
that will bridge the gap, there are two main categories (types
I and II) of robustness, each with a subcategory. Short- and
long-term uses determine which category should be selected
to achieve a given M&S objective, and that in turn impacts
which model type, inductive or synthetic, may be best. A
model cannot be robust in all ways. Analogues in the ﬁrst
category (type I) are robust to context changes, yet fragile to
changes in referent. Some of these analogues can still be
abstract enough to work for families of referents. Analogues
in the second category (type II) are robust to referent
changes, yet fragile to changes in context. Some analogues
within this category can still be abstract enough to work for
families of context. Wet-lab models can be similarly classiﬁed.
For example, MDCK cells can be cultured under many
different conditions with a variety of additives; the cells are
robust to context changes. However, as epithelial cells, they
cannot mimic cardiac myocytes and in that way they are
fragile to changes in referent. Embryonic stem cells can be
prodded to transform into representations of many different
cell types, but to be maintained as stem cells their environ-
ment must be tightly controlled; they are robust to referent
changes, yet fragile to changes in context. Synthetic and
inductive models often identify more strongly with one of
these categories, as illustrated in Fig. 11B. A fully synthetic
and concrete analogue, such as the ISL, is robust to changes
in context, yet fragile to changes in referent. It can be used to
represent a liver in almost any context, but it cannot be used
to represent a lung (however, some of its parts could be
reused in a lung analogue). The generic two-layer subsystems
used by An in the fourth example are robust to changes in
context, and they have contextual patterns suitable for
multiple referents. The ORGAN subsystems are synthetic, yet
abstract enough to represent other organs or tissues. A fully
inductive, detailed, PBPK model is expected to be robust to
changes in referent, yet it is fragile to changes in context. The
same model can be used to represent any number of
individuals and even different mammals, but only under
similar conditions. Traditional PK and PD models are
sufﬁciently abstract and general to be robust to changes in
referent within referent patterns across contexts. Conse-
quently, such models can be used to characterize data from
many different referents. The patterns in the data can arise
during different experimental contexts.
Models grounded to a metric space or hyperspace
(discussed in “How a Model is Grounded Impacts How It
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Can and Should be Used”) are robust to changes in referent
while being fragile to changes in usage or experimental
protocol. Inductive models tend to be grounded absolutely
because they model relations between variables or quantities,
not qualities or mechanisms. However, a generalized induc-
tive model (e.g., exponential decay, saturation, or a sigmoid)
can easily show qualitative relationships between quantities.
Such models can be robust to variations in the ratios between
the quantities even though they depend fundamentally on the
quantities they relate.
Relational models are robust to changes in use or
experimental protocol, yet they are fragile to changes in
referent. It is natural for synthetic models to be internally
grounded because they model relations between identiﬁed
and hypothesized components. A more generalized and
abstract synthetic model, such as cellular automata can show
organizational patterns between constituents. Consequently,
it can be robust to changes in referent, when the various
referents have similar organization.
In general, because inductive models tend to be robust to
changes in referent, and synthetic models tend to be robust to
changes in context, we recommend synthetic analogues for
explanation and hypothesis generation earlier in R&D and
inductive models for prediction and late-stage hypothesis
falsiﬁcation. When synthetic analogues are relational, they
are best for knowledge embodiment.
The vision presented in the Introduction requires
analogues with long lifecycles. To have long lifecycles,
analogues must be capable of adjusting easily to incorporate
new knowledge. This process requires using all three forms of
inference (94). It is noteworthy that many inductive models
have short lifecycles; some are never used again following
their initial application. Synthetic and inductive models have
different adjustment capabilities depending on the type and
source of the data. When new knowledge comes from
changes to context, then a synthetic model will be most
appropriate. An example of change in context would be many
different types of wet-lab experiments using the same cell
line. The latter is often the case for wet-lab models used early
in support of R&D. When the new knowledge comes from
well-studied changes to the referent, then an inductive model
is most appropriate. An example of the latter would be an
expanded, phase four clinical trial.
How a Model is Grounded Impacts How it Can
and Should be Used
& Knowledge embodiment requires synthetic analogues
that are relational.
& Inductive models are typically grounded to metric
spaces.
& Metric grounding complicates combining models to
form larger ones.
& Relational grounding enables ﬂexible, adaptable
analogues, but requires a separate analogue-to-refer-
ent mapping model.
& Biomimetic analogues designed to support drug
discovery and development must have long lifecycles.
As stated earlier, the units, dimensions, and/or objects to
which a variable or model constituent refers establish
groundings. Inductive models are typically grounded to
metric spaces. So doing provides simple, interpretive map-
pings between output and parameter values and referent
data. Because phenomena and generators (in Glossary) are
tightly coupled in such models, the distinction between
phenomenon and generator is often small. Metric grounding
creates issues that must be addressed each time one needs to
expand the model to include additional phenomena and when
combining models to form a larger system. Adding a term to
an equation, for example, requires deﬁning its variables and
premises to be quantitatively commensurate with everything
else in the model. Such expansions can be challenging and
even infeasible when knowledge is limited and uncertainty is
high, as on the left side of Fig. 11A. A model synthesized
from components all grounded to the same metric spaces—a
PBPK model for example—is itself grounded to the Cartesian
composite of all those metric spaces. The reusability of such a
model is limited under different experimental conditions or
when an assumption made is brought into question.
Grounding to hyperspaces increases ﬂexibility. A hyper-
space is a composite of multiple metric spaces (and possibly
non-spatial sets). Grounding to a hyperspace provides an
intuitive and somewhat simple interpretive map (see (95)).
Phenomena and generators are more distinct, because
derived measures will often have hyperspace domains and
co-domains, making them more complex as interpretive
functions. Hyperspaces are often intuitively discrete, so they
do not require discretization. They thus handle heterogeneity
better than does a model grounded to a metric space. The
High Level Architecture (IEEE standard 1516-2000) and
federated systems for distributed computer simulation sys-
tems are examples of hyperspace grounding. Their focus is to
deﬁne interfaces (boundary conditions) explicitly so that
components adhere to a standard for such interfaces.
Dimensionless, relational grounding is another option. In
equation-based models, dimensionless grounding is achieved
by replacing a dimensioned variable with itself multiplied by a
constant having the reciprocal of that dimension. That trans-
formation creates a new variable that is purely relational. It
relies on the constant part of a particular context. The
components and processes in synthetic models need not have
assigned units; see (65,96,97) for examples. The ﬁrst, third,
and fourth of the above examples use relational grounding:
each constituent is grounded to a proper subset of other
constituents. Relational grounding enables synthesizing ﬂex-
ible, easily adaptable analogues. However, a separate map-
ping model is needed to relate analogue to referent
phenotypic attributes.
Hybrids of the above grounding methods are also
possible. Some models can be synthesized by plugging
together components that are simpler models. For example,
in (80) output of metrically grounded, equation-based models
of subcellular molecular and cell cycle details contribute to
rules used by cell level agents. Such coupling makes them
somewhat relational because not every component must be
connected to every other component (or adhere to a standard
adhered to by all other components, as with the High Level
Architecture). However, their synthesis will depend in a
fundamental way on their grounding, sometimes to a metric
space, as in (98,99). The High Level Architecture (and
similar) standards can be considered as hybrids, because they
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provide openness and extensibility that allow some sub-
systems to integrate based on one standard and others to
integrate based on another standard.
Biomimetic analogues designed to support drug discov-
ery and development research are expected to evolve and
become more realistic and useful. Consequently, those that do
will have long lifecycles. Some will mature to become virtual
tissues and organs: components in virtual patients. For these
analogues, we suggest they begin as relational analogues and
remain so to the degree feasible, and that separate mapping
models be developed in parallel.
Synthetic analogue development to date by different
groups has managed the grounding issue differently. Twelve
examples are discussed brieﬂy in the Appendix.
Experimenting on Synthetic and Inductive Analogues
& Synthetic models are relatively speciﬁc, particular,
and concrete; inductive models are relatively general,
representative, and more abstract.
& Experiments on inductive models will discover char-
acteristics of the data from which the model was
induced; experiments on synthetic models will dis-
cover characteristics of the composition, the mecha-
nisms, and the model’s systemic phenotype.
& When trying to explain a system about which we are
ignorant or uncertain, use abduction: it is ignorance-
preserving.
& Synthesis facilitates knowledge discovery by helping
to speciﬁcally falsify hypotheses.
& Inductive models preserve the truth about patterns in
data. Synthetic models exercise abduction while
representing knowledge, uncertainty, and ignorance.
We argue for conducting experiments on computational
analogues as if they were naturally occurring organisms or
tissues. That is precisely what is done with very complex
software and hardware systems developed purely for engi-
neering purposes (e.g. ﬂight code for an automatic pilot).
However, in these engineering contexts, the purpose behind
such testing is to clamp down on the exhibited variation and
ensure that it stays within speciﬁed, controlled tolerances.
When designing and planning wet-lab experiments, we
include engineering tasks such as clamping down on the
variation of those parts that are not objects of the experiment,
such as temperature, pH, pO2, etc. The difference is that
those wet-lab experiments have a different objective: to
explore the living component of the system. The tightly
controlled, well-understood, predictable parts of the support-
ing laboratory equipment are ancillary to the primary
purpose, which is to reﬁne and increase our understanding
of the biological material being studied.
If we replace the biological material with a computa-
tional analogue in a supporting framework like the one
described in Fig. 4, does it still make sense to use the whole
apparatus to reﬁne and increase our understanding of a
smaller component of the system, such as the simulated cells
in Fig. 4? The answer depends on the nature of that model
and the model’s current location in model space. If it is a
straightforward implementation of, for example, a simple
mathematical equation that is well understood, then the
answer is “no.” Of the models in the references cited in
Supplemental Material, the vast majority developed within
the past 15 years required considerable experimentation.
That is because the phenotype (as in Fig. 3) resulting from the
initially conceived mechanism was too far removed from
targeted phenotypic attributes. Experimentation (several
cycles of a protocol such as the one in the next section) was
needed to locate a region of model space (mechanism space)
for which the phenotype was more biomimetic.
Both inductive and synthetic methods depend differently
on the means and measures used to gather the data and
related information that becomes the focus of the model
engineering effort. Inductive models contain an inherent
commensurability amongst the measures, because induction
ﬁnds and reproduces connected patterns in whole data sets.
Synthesis, however, combines heterogeneous data with infor-
mation from disparate sources and discovers ways to compose
them; some information sources are ad hoc, whereas others
are highly methodical. Even though the methods are funda-
mentally different, both inductive and synthetic models of
biopharmaceutical interest will often be appropriate for
experimentation.
Experiments on any model—mental, wet-lab, inductive,
or synthetic—can help the scientist think about and discover
plausible characteristics of a referent system’s mechanisms.
Experiments on inductive models do so by exploring charac-
teristics of the data from which the model was induced. That
is because the mappings are among data, conceptualized
mechanisms and referent, as illustrated on the left side of
Fig. 2. Experiments on synthetic models do this by exploring
model organization (how components co-operate/interact),
which is hypothesized to map to referent organization, as
illustrated by mapping C on the right side of Fig. 2.
Both modeling types have their strengths and weak-
nesses. Inductive models, because they rely directly on the
measures used to take the data, are susceptible to the fallacy
of inscription error (the logical fallacy of assuming the
conclusion and programming in aspects of the result you
expect to see). This weakness is a natural result of the
combination of the extrapolative properties of induction and
the truth-preserving properties of deduction. By contrast, as
discussed in (100), synthetic models, like the examples
described in “Analogues: From In Vitro Tissues to Interacting
Organs,” can contain abiotic and arbitrary artifacts, assump-
tions, and simpliﬁcations made for the convenience of the
builders. Note the partial overlap of phenotypes in Fig. 3.
These properties provide direction for when one style should
be preferred over the other. When trying to clearly specify
the parts of a referent about which we are ignorant or
uncertain, an ignorance-preserving technique like abduction
combined with synthetic M&S should be the center of
attention. When trying to specify the parts of a referent
about which we have deep knowledge, a truth-preserving
technique like deduction should be the focus. Where we
possess enough reliable knowledge to warrant extrapolation
and precise prediction, induction should be the focus. Hence,
synthesis can be most useful as an upstream modeling method
focused on discovering and falsifying hypotheses during
knowledge discovery and synthesis, and while honing down
and selecting hypotheses that are most believable. When we
become conﬁdent of the generative mechanisms, inductive
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counterparts of synthetic analogues can kick in, allowing us to
approach engineering or clinical degrees of understanding,
intervention, and prediction. Inductive models are best for
preserving the truth about patterns in data. Abductive
synthetic models are best for exercising abduction and
representing current knowledge and beliefs clearly, as well
as areas of ignorance and uncertainty.
When R&D goals require the capabilities of both
modeling methods, both model types can be implemented
for parallel simulations within a common framework (101). In
the sections that follow, we identify several important issues
and discuss them in context of both synthetic and inductive
M&S. Background information on computational models in
support of scientiﬁc discovery is provided in the Appendix.
The Scientific Method in Iterative Analogue Refinement
& Conceptualmechanisms can be ﬂawed inways that only
become obvious after they are implemented syntheti-
cally.
& Following a rigorous protocol facilitates generating
multiple mechanistic hypotheses and then eliminating
the least plausible through experimentation.
& An iterative model reﬁnement protocol is the heart of
abductive, mechanism-focused, exploratory modeling.
The scientiﬁc method provides a procedure for investiga-
tion, the objective of which is knowledge discovery (or
questioning and integrating prior knowledge). The method
begins with phenomena in need of explanation or investigation.
We pose hypotheses and then strive to falsify their predictions
through experimentation. The traditional inductive modeling
approach illustrated on the left side of Fig. 2 is often part of a
larger scientiﬁc method that includes wet-lab experiments. On
its own, however, inductive modeling is not scientiﬁc because
new knowledge (about the referent) is not generated.
The stages in scientiﬁc M&S are illustrated on the right
side of Fig. 2. The assembly of micro-mechanisms in each of
the four examples in “Analogues: From In Vitro Tissues to
Interacting Organs” was a hypothesis. Each execution was an
in silico experiment. Measures of phenomena during execu-
tion provided data. When that data failed to achieve a pre-
speciﬁed measure of similarity with referent wet-lab data, the
mechanism was rejected as a plausible representation of its
wet-lab counterpart (for a detailed example, see (65)). In all
four examples discussed in “Analogues: From In Vitro Tissues
to Interacting Organs,” many mechanisms were tested and
rejected en route to the mechanisms discussed in the cited
papers. Multiple rounds of iterative reﬁnement followed by
mechanistic failure illustrate the fact that complex conceptual
mechanisms can be ﬂawed in ways that are not readily
apparent to the researcher. The ﬂaws only become obvious
after we actually invest in the effort to implement and test the
mechanism synthetically.
The iterative analogue reﬁnement process beneﬁts from
following a protocol. We have used the protocol presented in
Fig. 12 successfully (65,75,81,96,97). It strives to adhere to the
guideline of parsimony, which is important when building
agent-oriented analogues that are expected to become
increasingly complex. The protocol facilitates generating
multiple mechanistic hypotheses and then eliminating the
least plausible through experimentation.
The iterative model reﬁnement protocol is the heart of
abductive, mechanism-focused, exploratory modeling. When
faced with the task of building a scientiﬁcally relevant, multi-
attribute analogue in the face of signiﬁcant gaps in the body
of knowledge used to guide the process, parameterizations
and model components must strike a ﬂexible balance
between too many and too few. Doing so can be complicated
by the fact that a validated, parsimonious, multi-attribute
analogue will be over-mechanized (“over-parameterized”) for
any one attribute. Too many components and parameters can
imply redundancy or a lack of generality; too few can make
the model useless for researching multi-attribute phenomena.
Scientiﬁc progress can be measured in scientiﬁc M&S
protocol cycles completed. It follows that we want to make
the process as easy as possible. Decisions made at the
beginning and during the ﬁrst protocol cycle can dramatically
impact the level of effort required to complete subsequent
cycles. Strategies that can work well for inductive M&S may
not be appropriate for synthetic M&S.
Making Predictions Using Synthetic Analogues
& Synthetic models make predictions about component
relations; inductive models make predictions about
variable relations and patterns in data.
Fig. 12. An iterative protocol for reﬁning and improving synthetic
analogues. Abductive reasoning may be required at steps 4–8.
Induction and deduction occur during steps 5–7.
2390 Hunt et al.
Synthetic analogues are ideal for discovering plausible
mechanisms, relations between components, and mechanism-
phenotype relationships. They are best for exercising abduc-
tion and representing current knowledge. They are good at
explanation. Because of the uncertainties reﬂected in sto-
chastic parameters and mappings to the referent, they are not
as good as inductive, equation-based models at precise,
quantitative prediction; their predictions will be “soft.”
However, they can make effective relational predictions.
Synthetic models make predictions about component rela-
tions (quantitative or qualitative), and inductive models make
predictions about variable relations (quantitative or qualita-
tive) and patterns in data. An ISL, for example, can be used
to make predictions about where and how within the system
two DRUGS administered together may effectively interact.
However, when such predictions are absolutely grounded (via
the grounding map), then an important distinction between
synthetic and inductive model predictions lies in the error
estimate for the prediction.
IMPACT OF M&S ON SCIENTIFIC THEORY
Instantiating and Exploring Theories of Translation
& Theories of translation will arise from contrasting
analogues.
A precondition for understanding if and when observa-
tions on wet-lab research models can translate to patients
(and vice versa) is to have a method to anticipate how each
system will respond to the same or similar new intervention at
the mechanism level. The ISLs (21) and the other analogues
described above enable developing that method. Building an
analogue of each system within a common framework allows
exploration of how one analogue might undergo (automated)
metamorphosis to become the other. When successful, a
concrete mapping is achieved. Such a mapping is a hypothesis
and an analogue of a corresponding mapping between the
two referent systems, as in Fig. 8B. The analogue mapping
can help establish how targeted aspects of the two referent
systems are similar and different both at the mechanistic level
and, importantly, at the systemic, emergent property level.
The vision is that the analogues along with the metamorpho-
sis method can be improved iteratively as part of a rational
approach to translational research.
Abductive Reasoning and Synthetic M&S Can Help Manage
the Information and Data Glut
& Synthetic analogues help alleviate the information
and data glut.
& Combining synthetic with inductive models better
preserves and progressively enhances knowledge.
& Exclusive reliance on inductive and deductive meth-
ods starves R&D of abductive opportunities.
We concur with An’s observations regarding dynamic
knowledge representation and ontology instantiation
(18,102), and argue that the data and information glut
impacting pharmaceutical R&D is caused by our knowledge
schemes and knowledge bases (into which that data and
information should ﬁt) being incomplete or unnecessarily
abstract. The available schemes are largely represented in the
formalized, prosaic Methods sections of published scientiﬁc
papers, and to some extent in Discussion sections; they are
also represented within similar documents within organiza-
tions. The majority of that information consists of relation-
ships between quantities, yet the schemata available for
cataloging relationships between quantities are ambiguous.
Examples of elements of schemata are logP, clearance, level
of gene expression, media composition, response, etc. The
schemata are designed purposefully to lose, forget, abstract
away, and/or ignore some concrete details of experiments and
cases. On one hand, such abstraction is good because it
facilitates the extraction of fundamentals and major trends:
the take-home messages from speciﬁc experiments. On the
other hand, there are many concrete details which, were they
captured by the schemata, would permit a more complete
cataloging of experiments and observations. In some cases,
such improvements could enable semi-automatic extraction,
hypothesis generation, evaluation, and hypothesis selection.
We posit that complementing the current schemata with
synthetic analogues, advanced progeny of the four examples
in “Analogues: From In Vitro Tissues to Interacting Organs,”
would be a signiﬁcant step toward more satisfactory sche-
mata. The process would begin alleviating the information
and data glut, and allow semi-automated hypothesis gener-
ation/testing and theory development.
A synthetic analogue is a schema for biomimetic
constituents. An inductive model is a schema for quantities.
Either, alone, is inadequate. Together, knowledge generated
can be preserved and its value progressively enhanced as the
process advances.
A natural consequence of the rapid advances in –omic
technologies, which are quantitative, coincident with the rise
of molecular biology, coupled with advances in computational
methods, has been a heavy focus on forward mappings and
inductive models (discussed further under Generator–phe-
nomenon relationships in the Appendix). Methods to support
abduction and synthesis—scientiﬁc M&S—have not advanced
as quickly. A consequence is the current information and data
glut. Methods (knowledge schema) for rapid hypothesis
generation and reﬁnement are sorely needed (102).
We suggest that a contributor to the inefﬁciencies respon-
sible for signiﬁcant rates of failures late in development is the
fact that scientists and decision-makers currently translate
results and conclusions from wet-lab experiments to patients
using conceptual mechanisms and mappings where some
assumptions are intuitive and unknown, and thus unchallenge-
able. It has been argued that mathematical, systems biology
models will help address this issue, but we believe the situation is
actually made worse by over-reliance on inductive and deduc-
tive computational modeling methods that reduce opportunities
for and ignore the importance of abductive reasoning. Scientiﬁc
M&S provides themeans to concretely challenge those concepts
and preserve those that survive.
Discovery and Development Research Needs Explanatory
Models to Complement Inductive Models
& Synthetic analogues are best at explanation; inductive
models are best at precise prediction.
& Strong theory and good science depend on having
both heuristic value and predictive value.
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& When in pursuit of newmechanistic insight, the emphasis
should be on generation and exploration of multiple
hypotheses.
& We risk being stuck on the current scientiﬁc plateau until
we implement complementary methods to generate and
select from competing, explanatory hypotheses.
The explanatory power and heuristic value of a hypoth-
esis come from its ability to make speciﬁc statements about
the network of micro-mechanisms (lower level generator–
phenomenon relationships; see Appendix for further discus-
sion) that produce a rich phenotype. Synthetic analogues are
best at explanation. On the other hand, the predictive power
of a hypothesis comes from its ability to make speciﬁc
statements about the end conditions (the context, state,
situation, etc. it will obtain) given some initial conditions.
Inductive models are best at prediction. Strong theory and
good science depend on having both heuristic value and
predictive value. Recall Richard Feynman’s dictum: “what I
cannot create, I do not understand.” Correlations are devoid
of heuristic value, yet they can provide predictive value.
An attractive property of inductive models is that, because
they relate quantities, they are relatively easy to validate.
However, because they do not relate speciﬁc components, the
mechanisms and the generator–phenomenon map they are
intended to represent remain conceptual. All the hypothesized
generators for the phenomena modeled are embedded in the
prosaic and pictorial descriptions of the models, not in
the mathematics. The descriptions are not actually part of
the induced model. There is only the conceptual linkage
illustrated on the left side of Fig. 2. That situation makes
generator falsiﬁcation very difﬁcult because many generator
conﬁgurations and different sets of generators can produce
the same phenomena, which, when measured, contains
patterns speciﬁed by the validated mathematical, inductive
model. Within the biomedical, pharmaceutical, and biotech-
nology domains, that difﬁculty has resulted in too little focus
on falsiﬁcation and an overzealous focus on data validation
(of patterns), as distinct from the more heuristic forms of
validation (103). When in pursuit of new mechanistic insight,
the emphasis should be on generation and exploration of
multiple hypotheses. The validation process should involve
repeated attempts to falsify a population of hypotheses and
select the survivors. As demonstrated herein, the technology
and methods are available to complement any mechanisti-
cally focused inductive model with synthetic explanatory
modeling methods that offer concrete analogues of the
conceptualized mechanisms. Without complementary meth-
ods to generate and select from competing, explanatory
hypotheses, we risk remaining stuck on the current scientiﬁc
plateau. Information and data will continue to grow, further
overwhelming the individual scientist’s ability to reason
scientiﬁcally and to decide which therapeutic candidates to
select and which to eliminate.
Scientific Multi-modeling
& Modeling a wet-lab biological system is multifaceted,
requiring all three reasoning methods along with
multiple models and model types.
& The phases of multi-modeling are construction, evalua-
tion and selection, and reﬁnement.
Scientiﬁc modeling, like wet-lab science, requires use of
all three modes of inference. It also requires development of
inductive and synthetic models to provide heuristic as well as
predictive value. Use of the three inference modes requires
developing and using multiple models. Multiple models are
necessary because discovering plausible forward maps
requires targeting multiple phenomena (and multiple meas-
ures). Discovering plausible inverse maps requires exploring
multiple generators (and multiple measures).
Any satisfactory synthetic analogue can be falsiﬁed by
placing additional demands on its phenotype, by selectively
expanding the set of targeted attributes to which it is expected
to be similar (Step 8a in Fig. 12). A beauty of synthetic
analogues of the types described in “Analogues: From In
Vitro Tissues to Interacting Organs” is that we can observe
the networked micro-mechanisms and “see” what mechanistic
features were most likely responsible for the analogue’s
inability to survive falsiﬁcation. The data in Fig. 9 are an
example. This knowledge improves insight into the referent
mechanism and is an example of the analogue’s heuristic
value. If all existing analogues have been falsiﬁed, then one
must step back and invent new analogues containing new
micro-mechanistic features that may survive falsiﬁcation.
Following the preferred (but more resource-intensive)
approach, two or more somewhat different, yet equally
plausible analogues are created, and one or more survives
falsiﬁcation. The process of analogue falsiﬁcation and survival
provides valuable new knowledge about the analogue and
about the referent micro-mechanisms.
Falsiﬁcation of a synthetic analogue requires a precise
criterion, one that requires the use of inductive models. The
quantitative comparison of comparable analogue and wet-lab
phenomena typically focuses on data features, a task for
which inductive models are ideally suited. Statistical models
are also useful. Because multiple attributes are always being
targeted, the falsiﬁcation decision will be based on multi-
attribute comparisons. Following the repeated cycles of
reﬁnement in Fig. 12, analogues become more resistant to
incremental falsiﬁcation, and begin earning trust. Trustable
synthetic analogues must be robust to both context variance
and constituent variance. To build trust, the analogue must be
groundable using absolute units (clock time, ml, moles, etc.),
which requires concurrent development of mapping models.
It becomes clear that modeling a wet-lab biological system to
expedite research progress is a multifaceted undertaking
requiring exercising all three reasoning methods and the
development and use of multiple models and multiple model
types. These tasks will be facilitated and made easier by
insisting on analogues that strive to exhibit the capabilities in
the Text Box. Further, multi-modeling has three different
phases: construction, followed by evaluation and selection
(for or against), and reﬁnement.
Complement, Not Replace; Evolution, Not Revolution
& Synthetic methods complement inductive methods.
& Synthetic methods can help ferret out bad information.
& Inclusion of synthetic M&S early in R&D will
accelerate the process.
One might surmise that because synthetic M&S methods
draw extensively on recent computer science advances and
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thus are relatively new, that they are intended to replace the
“old” inductive methods. That is not the case: M&S efforts
complement wet-lab efforts. As illustrated in Fig. 11, synthetic
methods complement the well-established inductive methods.
Synthetic M&S simply provides a dramatic expansion in
options for using M&S to advance science and facilitate
discovery, especially where mechanistic insight is needed,
toward the left side of Fig. 11A. Synthetic M&S is a product
of the evolutionary process that is driving computational
M&S methods to become more biomimetic, to bridge the gap
in Fig. 1.
Integration of various published results into a synthetic
analogue accomplishes two things: 1) it helps build schemata
for knowledge (and ignorance) representation, and 2) it also
provides a mechanism for the curation and maintenance of
the embedded knowledge. Both are possible because compo-
nents and mechanisms in synthetic models are concrete,
whereas those in inductive models are conceptual. Because
synthetic models are heuristic, falsiﬁcation during the evalua-
tion of the Fig. 12 protocol will spawn abductive explanations
for the hypothesis’s failure. The weakest part of the failed
analogue will most often be some new feature of the
hypothesized mechanisms. However, in some cases, the
weakest part may be some previously added component or
logic drawn from badly designed experiments or invalid or
false conclusions. The heuristic nature of synthetic models
can highlight and facilitate the correction or revisitation of
those previously accepted components; see (65) for an example.
Synthetic M&S in conjunction with wet-lab experimentation
and inductive M&Smethods curates and maintains the integrity
of current knowledge but also acknowledges our current state of
ignorance.
One can argue that progress in a pharmaceutical R&D
effort is tied to opportunities for mission-centered abductive
reasoning. Circumstances requiring abductive reasoning asso-
ciated with results of wet-lab experiments are common during
discovery and early development. Opportunities to exercise
abductive reasoning have traditionally been tied to the
number of experiments and their duration. A complementary
synthetic M&S effort can be added incrementally. With that
effort comes a dramatic increase in opportunities for goal-
directed abductive reasoning. If progress and better decision-
making are positively correlated with knowledge and insight
gained through goal-directed abductive reasoning, then we
can anticipate that the early inclusion of scientiﬁc synthetic
M&S will accelerate the process.
CONCLUSIONS
We presented a case that the means are currently
available to speed the progression from discovery to clinical
use and production of new therapeutic products. We showed
that the process requires multi-modeling (multi-scale, multi-
formalism, multi-technology, multi-person, multi-referent,
multi-context, etc.) within a common framework, and that it,
in turn, requires taking full advantage of computers during
R&D. Multi-modeling that can be semi-automated is the
M&S frontier. For multi-modeling to be successful, it must
become methodically scientiﬁc. Scientiﬁc M&S will accelerate
the above progression by facilitating fast-paced cycles of
hypothesis (about mechanisms) generation, selection, and
falsiﬁcation. Each cycle requires synthetic modeling and
simulation coupled with inductive methods; during such a
cycle, abduction drives the creation of mechanistic hypoth-
eses. Those mechanistic hypotheses that meet criteria are
selected for experimentation (wet-lab and in silico) designed
to ensure that only those with explanatory, heuristic value
survive falsiﬁcation. The cyclic process exercises and lever-
ages the mental models of domain experts in new ways.
However, the new knowledge created can be instantiated and
retained within the analogues and their framework making it
immediately accessible to all members of an R&D organ-
ization. We explained that making M&S scientiﬁc requires
extension of rigorous methodology to include planned use of
all three reasoning methods: abduction, induction, and
deduction. So doing will make M&S a methodologically
sound, increasingly productive tool similar to wet-lab models,
laboratory equipment, and large-scale experiments.
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APPENDIX
Glossary
Abduction: arrival at a conjecture based on a pattern
observed in one or a few particular cases; construction
of hypothetical speculation (consistent with current
knowledge) about the process by which an outcome
(phenomenon) came to be, where the hypotheses are
all equally reasonable as long as they lead to the
outcome; arrival at a conjecture (hypothesis) that
would, if true, explain the relevant evidence (abduc-
tive reasoning is discussed following the Glossary)
Agent: [technical] an object within an object-oriented pro-
gram that can schedule its own events [within an
analogue: it is quasi-autonomous; it senses and is part
of its environment; it pursues and can revise an agenda
within a larger script; it is identiﬁable by an observer as a
cause of an effect; its attributes and actions may be
designed to represent biological counterparts, whereas
others will deal with issues of software execution]
Agent-based: something formulated with or built up from
agents; [in agent-based modeling] a model designed for
simulation in which quasi-autonomous agents are key
components
Analogue: anything that is analogous or similar to something else,
and that exists and operates in isolation even in the absence of
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a referent; a system that has aspects and attributes that are
similar to those of a referent system; a model implemented in
software that, when executed, produces phenomena that
mimic those of the model’s referent
Aspect: the perspective taken when a system is observed; one of
many functional effects that results when a system executes
Complex: consisting of interconnected or interwoven parts;
involved or intricate [a complex system may have many
cause–effect relationships or one in which it is difﬁcult to
tease out cause–effect relationships]
Deduction: automatic and/or mechanical transformation of a set
of statements; purely mechanical (syntactic) transformation
of the premises to a conclusion; transformation of assump-
tions into conclusions within a formal system [where if the
assumptions are true, the conclusions and every intermediate
step in the transformation are also guaranteed to be true]
Discrete event: a measurable, individual transaction or status
change with speciﬁc start and end timing that can be
attributed as a source of requirement
Discrete Event Simulation: a simulation in which the model
evolves over time by representing changes as separate
events [in a continuous simulation, the system evolves as
a continuous function (differential)]
Emergence: a descriptive term for systems that have complex
maps between mechanisms and phenomena, where it is
not obvious how the properties and characteristics of the
mechanisms generate the observed phenomena
Generator: a process or event that causes, produces, or
contributes to a phenomena (generator–phenomenon
relationships are discussed in a following section)
Granularity: the extent to which a system is subdivided; a
measure of the size (degree of discretization) of compo-
nents that make up a system
Grounding: units, dimensions, and/or objects to which a
variable or model constituent refers
Induction: arrival at a conjecture (universal conclusion) based
on a pattern observed in many particular cases; general-
ization: reasoning from detailed facts to general principles;
generalization drawn from patterns in observed data
Instantiate: to construct a particular, concrete instance or
individual member of a class
Object-oriented programming (OOP): at the risk of over-
generalization, an effort to make software more tacit and
intuitive; classes are deﬁned so as to package logic/code
and state variables inside a wrapper, thereby separating
and abstracting an object’s interface (behavior) from its
implementation (mechanism); this separation facilitates
the synthetic construction of many systems of objects
without re-engineering the internals of any object used;
this property makes OOP software more easily adapted,
disassembled, and reassembled into other system organ-
izations; it makes an ideal method for constructing
software for biomimetic analogues
Scientiﬁc modeling and simulation: a particular use of models
within a larger context in which 1) the model is abductively
or inductively inferred and in which a deductive analogue is
designed and constructed to be the object of experimenta-
tion, and 2) where experimentation is characterized by
cycles of abductive, inductive and deductive reasoning
focused on generating, testing, and falsifying hypotheses
about mechanisms and their relationships to phenomena
Simulation: a real, implemented, or instantiated model during
execution; a process of generating behavior of a model
using a simulator; execution of a model by a simulator
Synthetic model: a model system constructed from extant,
autonomous components whose existence and purpose
are independent of the model they comprise; one formed
speciﬁcally by combining elements, often varied and
diverse, so as to form a coherent whole
Further Explanations
Representing Compounds: One COMPOUND within one SS
grid space (in Fig. 7C) can be viewed as mapping to a wet-lab
lower limit of detection. For example, it may be viewed as the
limit of detection of referent compound in a biopsy sample
that has a volume 1/5,000th that of an average lobule. At that
limit, some biopsy samples will test negative for drug, even
though we are conﬁdent some is present. By analogy, an
empty space within the ISL during simulation cycle maps to
“no detectable drug.” Even though we can trace the change
in location of a speciﬁc COMPOUND during execution, there is
no mapping to corresponding changes in location for speciﬁc
drug molecules. Drug molecules comprising the amount to
which a COMPOUND maps during one simulation cycle are not
identical to those to which that COMPOUND maps during the
next simulation cycle.
Inductive, deductive, and abductive reasoning: Conditions
supportive of all three reasoning methods are sketched in
Fig. 11A. Induction is arrival at a conjecture (universal
conclusion) based on a pattern observed in many particular
cases. We start with induction because of its pervasiveness in
pharmaceutical and biological modeling domains. Because
induction begins with the measurement of a collection of
objects, it is fundamentally and foremost a method for
studying phenomena, not mechanism. That realization is
important. The measure that is deﬁned in order to take
measurements on the set of objects is a model. The data from
which a pattern is induced is a statement solely about the
phenomena for which the measure was designed. Hence,
every data set, and subsequently every inductive model, has
embedded in it the aspects or usage protocols plus premises
commensurate with the measure used to take the data.
Naturally, using more data or other information during
induction allows for a more ﬁne-grained model, including
induction over multiple dimensions and (though difﬁcult)
heterogeneous data types. In general, a model induced from
large sets of the same type data will be more precise, more
speciﬁc, and more suitable for prediction. On the other hand,
a model induced from lots of variant data (measures of
different phenotypic attributes) will be less precise but more
resilient and more general; its predictions will reﬂect greater
uncertainty. In the former context, one has to worry most
about over-ﬁtting data, which makes the model too speciﬁc to
a single data set to be useful. At the same time, one has to
worry about inducing a model that is too general and misses
crucial patterns in the data. Those two issues are broadly
recognized and appreciated in the ADMET, QSAR, and PK
literature.
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Often, the modeler is also interested in the generative
mechanisms responsible for the data. In those cases, features
of idealized, conceptual constructs (a feedback circuit, a two-
compartment model, etc.) can provide mechanistic insight.
This is particularly true when the mathematical description of
an idealized measure of a construct feature (given a set of
premises) is known to have a form that is the same (or nearly
the same) as the induced mathematical description (a sum of
exponentials, for example). How well the parameterized
features of the conceptual construct map to components and
features of the referent, along with the acceptability of the
premises, are separate issues outside the scope of this
discussion. The initially induced mathematical description is
prosaically expanded to include the conceptual features, but
remains a hypothesis about patterns in the data. The process
just described corresponds to the conceptual mapping arrows
on the left side of Fig. 2.
Deduction is automatic and/or mechanical transforma-
tion of a set of statements. It is the purely mechanical
(syntactic) transformation of the premises to a conclusion.
As such, no meaning (semantics) need exist for deductive
systems. All executing computer programs (absent human or
real-world interactions) are deductive systems. Likewise,
mathematical transformations within domains like algebra,
calculus, or CA are also deductive systems. The most
fundamental element of deduction is the engine that actually
makes the transformation. In the case of a computer program,
the instruction pointer provides the impetus for transforma-
tion. In mathematics, the engine is the human manipulating
the symbols. A simulation is an operating, deductive system
designed to mimic the behavior of some referent. Its alphabet
and grammar are speciﬁed in part by the language in which
the program is written and in part by the constructs the
programmer creates. The premises are statements about the
initial conditions of the program. The conclusions are state-
ments about the ﬁnal conditions of the program. The
conclusions (of interest) become the outputs or “behaviors”
of the simulation, but no new knowledge can be created. Any
meaning applied to the premises, grammar, or conclusions are
inferred by those examining the program and simulation, and
so remain conceptual and hypothetical.
What about interactive programs? Are they deductive,
and if not, what are they? In a non-interactive simulation,
what is true in the beginning remains true at the end and in
between. The truth-preserving property of non-interactive
programs holds even in the cases where, for example,
variables take on values that oscillate, are stochastic, or
produce a chaotic time series. Thus, an inductive model
implemented as a deductive simulation is truth-preserving.
However, an interactive program (for example, one that
controls periodic blood sampling during an experiment, and
causes injection of an amount of insulin based on the reading
and its internal logic) can be written such that sentences are
added, modiﬁed, or removed over time. Such systems are
termed non-monotonic (104) because new premises (“facts”)
can change a conclusion that was formerly true to false, or
vice versa. As we argue in the text, scientiﬁc M&S involves
more than purely deductive (and monotonic) systems. Given
that argument, it is clear that, for example, a non-interactive
algorithmic implementation of a system of ordinary differ-
ential equations (even a very large system) is not a complete
model of a system; the supporting prose, diagrams, and
artwork typically provide the necessary context and mecha-
nism descriptions.
Abduction (105–109) is arrival at a conjecture based on
a pattern observed in one or a few particular cases.
Abduction is conceptualizing (multiple) mechanisms:
explanations that, if true, could account for or generate a
similar anomalous, interesting, or surprising observation.
Abductive inference involves hypothesis generation and
selection, and is an important occurrence during wet-lab
research. Abduction is most likely and appropriate for
ambiguous systems (the left side of Fig. 11A). The task of
resolving the ambiguity is best approached through multiple
aspects and with multiple mechanistic hypotheses measured
with multiple measures.
To illustrate abductive inference, consider the following
situation: measurements of an experimental treatment group
exhibit unexpected values when compared to those of control
groups and data from past experiments. Further, the results
do not ﬁt well with known categories of similar phenomena.
In such a situation, researchers offer many speculative,
candidate explanations: were this condition or circumstance
true, it could explain the anomalous or new observations.
Some explanations may focus on material used in the experi-
ment (a possible bad batch of reagent, etc.). Other explan-
ations may focus on the conduct of the experiment (the
samples may have been mishandled, etc). Others are ideas
about mechanistic explanations. Generation of varied explan-
atory hypotheses, some highly speculative, following the
observation of the anomalous behavior is part of abduction.
The next phase involves a process that narrows the competing
ideas to those deemed most plausible. Following abduction,
the consequences of these hypotheses are logically or
experimentally deduced, and then evaluated using induction.
After testing, when the set of plausible hypotheses is
dramatically reduced, those remaining represent the current
best explanation(s) until some new observation falsiﬁes one
or more of them. At that stage, the entire scientiﬁc reasoning
cycle may repeat itself.
The above cycle (Fig. 12) occurs frequently when
engineering and reﬁning a synthetic analogue. The behaviors
of the ﬁrst implementation often fall short, frequently far
short of expectations, even though it is the modeler’s best
hypothesis about how components should plug together to
obtain the targeted phenomena. That shortfall falsiﬁes the
best hypothesis. The modeler has learned that the selected
region of mechanism space is too abiotic. The modeler must
rethink plausible micro-mechanisms. The solution is to jump
to another region of mechanism space and experiment to
determine if the new micro-mechanisms produce phenomena
that are more similar to targeted phenomena. So doing
exercises creativity. When improvements are seen, the
modeler can conjecture that the new micro-mechanisms are
more biotic. Each failed cycle exercises thinking creatively
about plausible mechanisms. Each improvement in the
similarity of the analogue’s behavior to that of the referent
adds new knowledge and improves insight into referent
mechanisms. Both failed and fruitful cycles are often charac-
terized by abductive reasoning.
Like induction, abduction starts with a measure selected
by the researcher. As such, the hypothetical mechanisms
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inferred (current beliefs) are inherently and irrevocably
dependent upon the measure through which the phenomena
are deﬁned and revealed. They are aspect- and perspective-
dependent. Change aspect and/or perspective and the hypo-
thetical mechanisms inferred may change. Unlike induction,
however, abduction does not necessarily produce (overly)
precise or (overly) general mechanistic explanations. More
often, they are speciﬁc to the observation or experiment and its
context. That is because the focus of abduction is on the
current few interesting cases. The hypotheses (explanatory
models) must be elaborated through deduction followed by
validation through induction in order to learn how precise or
general each hypothetical mechanism actually is. For that
reason, abduction preserves ignorance, in contrast to the truth
preservation of deduction. The researcher is just as ignorant
after abducing an explanation as before. There is a spectrum
for abduction analogous to the precision-generic spectrum for
induction. It is heterogeneity–homogeneity. The number of
distinct aspects (model usage protocols) the measure tolerates
dictates the heterogeneity of the abduced model. For example,
an anomalous set of drug plasma levels at intervals after dosing
will produce a population of similar, explanatory hypotheses.
They can be described as being relatively homogeneous. On
the other hand, an anomalous set of measures that also
consider levels of a surrogate marker, blood pressure, muscle
tone, etc. will produce an array of very different hypotheses.
Because of that variety, they can be described as being
heterogeneous. Granted, an overly enthusiastic modeler can
construct a complex explanation for a simple phenomenon, but
there are philosophical, professional, and practical motivations
to minimize the complexity of the abduced model so that it is
only as complex as it must be to explain the heterogeneous set
of measured phenomena.
Grounding Examples: The following are twelve examples of
biomimetic, synthetic analogues (all agent-oriented) that
manage grounding differently, even though uses are broadly
similar. From ﬁrst to last, the analogues range from being
thoroughly grounded to metric space (and thus requiring
reengineering to reuse the analogue for referents having
different contexts) to being more relational (and thus
requiring a separate mapping model to quantitatively relate
analogue behaviors to referent behaviors).
Odell et al. (76) present a molecular mechanism for
positioning during cell division of the cleavage furrow during
cytokinesis. The analogue contrasts opposite effects of
dynamic and stable microtubules on cleavage furrow position-
ing. It uses a few hundred thousand differential equations to
keep track of how, via Newton’s and Fick’s laws, myriad
individual cytoskeletal elements (agents, e.g., MT “segments”
and individual MKLP1 motors) move, continuously with
time, through a spatial continuum of viscous cytoplasm in
response to forces these parts exchange after collisions
between them. As such, the analogue is thoroughly grounded
in metric space.
Zhang et al. (80) present a lattice-based model of tumor
growth, which uses a set of equations to represent epidermal
growth factor receptor signaling network in the extracellular
space, cell membrane, cytoplasm and nucleus. The epidermal
growth factor receptor signaling network regulates CELL DIVI-
SION, APOPTOSIS, and migration processes that collectively give
rise to tumor-like phenotypes. The authors parameterized their
model using measurements taken from the literature, and the
parameter values were grounded to metric space.
Bindschadler et al. (72) present a conﬂuent monolayer of
CELLS that is INJURED by forcibly removing a strip of CELLS.
The remaining monolayer HEALS through a combination of
CELL migration, spreading and PROLIFERATION. The authors
measured parameters of L1 ﬁbroblasts and used them to
construct their analogue. Components and rules used equa-
tions that had units of the in vitro measurements. The model
is agent-based, so, in theory, mechanisms could be dissociated
from speciﬁc units.
Christley et al. (53) present an analogue that was used to
mimic patterns of mesenchymal condensation in which cells
of the embryonic vertebrate limb in high-density culture
undergo chondrogenic pattern formation. They used wet-lab
values of diffusion coefﬁcients to specify other parameter
values, thus grounding the analogue to metric space. They
used parameter sweeping to discover which parameter
settings produced results most in agreement with in vitro
data. The model design was such that the mapping model,
rather than being merged with the analogue, could be made
separate.
Walker et al. (79) developed an agent-based analogue of
epithelial cells, and used it to simulate epithelial monolayer
growth in culture. A set of rules governed CELL cycle actions,
and was coupled with a physical model (equations) to account
for physicochemical determinants of CELL bonding and
movement. Separate mappings were used to draw quantita-
tive relationships between in silico and in vitro features.
Galle et al. (77) developed an individual, agent- and
physics-based representation of cells in a monolayer of
epithelial-derived cancer cells. TUMOR CELL shape change
was dependent on physical constants and forces, which
provided grounding to metric space. Cell parameters were
grounded to wet-lab dimensions. The applications discussed
were somewhat limited by the precise grounding.
Ridgway et al. (78) simulate diffusion and reaction
kinetics in a crowded virtual cytoplasm relying on metrically
grounded reaction rates. The authors invested considerable
effort in quantitative validation. This analogue has the
ﬂexibility to simulate different types of particles, but context
is limited by the precise grounding.
Garmire et al. (64) describe an in silico Transwell device
for the study of drug transport and drug–drug interactions.
Being agent-based, the analogue has a general form that
allows for its use with a wide range of different parameter
settings. However, the particular version described was care-
fully parameterized so that simulation results were directly
comparable to wet-lab results, and most values were
grounded in metric space.
Cai et al. (73) present an analogue that was used to
explore population-scale and CELL-scale behaviors in a
WOUND-HEALING CELL migration assay. The analogue uses
equation-based modeling, but the authors created and used
generalized dimensionless forms of the equations. The
individual-based analogue components were not grounded
to metric space, although the analogue was parameterized
using experimental observations.
Robertson et al. (74) present a multiscale analogue to
explore issues of morphogenesis, speciﬁcally mesendoderm
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migration in the Xenopus laevis explant model. Equation-
based, mass action kinetic models specify intracellular pro-
cesses. Events at the cell level used an agent-based model of
mesendoderm migration across a ﬁbronectin extracellular
matrix substrate. CELLS were grounded to time and the
dimensions of their grid space, which in turn were grounded
to metric space. Given the ﬂexible design, it should be
straightforward to uncouple the system and mapping models.
Engelberg et al. (75) represent cells using atomic agents
to better understand cell level principles of operation
enabling formation of stable, semi-spherical tumor spheroids
in vitro. The design was fully relational. Comparing simulated
with wet-lab observations used a separate mapping model.
However, because analogues were parameterized using
diffusion coefﬁcients and cell sizes, that grounding locked in
certain other parameter values.
Lam et al. (65) used a simpliﬁed perfused liver analogue
with some features similar to the ISL. The goal was
discovering plausible mechanistic details of hepatic drug
interactions. The analogue was fully relational. All quantita-
tive mapping from analogue to referent measures used
separate, simple mapping models.
Multi-agent platforms: A number of multi-agent M&S plat-
forms are available. Swarm (http://www.swarm.org) is an
established software framework supporting multiple pro-
gramming languages (110). RePast (http://repast.sourceforge.
net) is an integrated modeling environment that provides
visual modeling and machine learning libraries (111).
MASON (http://cs.gmu.edu/∼eclab/projects/mason) is a light-
weight Java-based framework with a modular visualization
package (112). NetLogo (113) and StarLogo (114) are easy-
to-use, integrated modeling environments based on a custom
programming language, Logo. All provide requisite features
for agent-based, discrete event simulation. These and other
M&S toolkits are reviewed in (115,116). As demonstrated in
the next section, agent-oriented analogues can develop into
complicated devices. Thorne et al. (55) have observed that, as
a consequence of that and the fact that building and working
with biomimetic, synthetic analogues is a relatively new
domain, it can be logistically difﬁcult to communicate all of
the relevant details. During a simulation, hundreds to millions
of different components can be in play. That makes many
simulation experiments computationally intensive, an issue
that can be addressed using advanced technologies such as
cloud computing.
Generator–phenomenon relationships within wet-lab models
and synthetic analogues: Because generator–phenomenon
relationships are at the heart of most synthetic modeling
efforts, deﬁnitions and clariﬁcations are needed. A generator
is a tangible object that exists in the real world. A purely
mathematical object is not a generator. A concept is not a
generator. However, a computer executing instructions com-
piled from the description of a mathematical object (in a
programming language) is a generator. A phenomenon is a
pattern or event that, in principle, is observable, experience-
able or perceivable by some other thing (no consciousness or
intention is required). Phenomena remain potentials until or
unless they are measured or used. Measures are a type of
model, with a referent and an analogue. Generators are
distinct from the phenomena they (help to) generate. Within
wet-lab systems there are many generator–phenomenon
layers, many of which are still unknown and unobserved. A
phenomenon in one generator–phenomenon layer can be a
generator in another generator–phenomenon layer. Forward
and reverse maps and generator–phenomenon relationships
are related. Deduction is a forward mapping from generators
to phenomena. Deduction and thus forward mappings
preserve knowledge. Knowledge preserved in a simulation is
not scientiﬁcally interesting. However, the measurement of
the phenomena generated can be interesting when there are
wet-lab counterparts measured similarly. All interesting
simulation efforts begin by deﬁning their measures, their
usage context, their experimental protocol, etc.
The exploration of an inverse map from phenomena to
generators (via abduction or induction) requires the
researcher to hypothesize generators that could result in the
observable phenomena. The question posed is this: given
phenomena, what hypothetical generators (and measures)
might generate them? When we ﬁnd a hypothetical generator
in the form of biomimetic mechanisms we are just as ignorant
of the wet-lab system as we were before, but we now have a
concrete instance of a plausible mechanism where before we
only had vague, unchallenged concepts. In the absence of
other concrete, competing theories, it can stand as the current
best explanation for the phenomena. A full study of any
inverse map requires abduction (several hypotheses), deduc-
tion (simulation), and induction (falsiﬁcation), and that can
only be done with concretizable hypotheses: synthetic ana-
logues. It cannot be done with hypotheses that remain
conceptual.
A generator–phenomenon map is not one-to-one. Many
generator compositions (mechanisms) can produce phenom-
ena, which when measured are indistinguishable. Also,
different phenomena can result from the same generator
composition. The same ISL micro-mechanisms and COM-
POUNDS can produce almost an endless variety of outﬂow
proﬁles. It follows that studying an inverse mapping requires
multiple, seemingly plausible hypotheses, which then compete
against each other during simulation experiments. Those that
survive spawn additional, more reﬁned hypotheses, following
an iterative reﬁnement protocol like the one in “The
Scientiﬁc Method in Iterative Analogue Reﬁnement.” Induc-
tively deﬁned models implicitly handle multiple generators
for the same phenomena. That is because they relate
quantities and measurements, and are therefore inherently
phenomenal. As stated in the text, they are robust to changes
in composition. Synthetically deﬁned analogues implicitly
handle multiple phenomena for the same generators. They
are inherently generative because they relate constituents and
objects: they are robust to changes in context.
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